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1 ABSTRACT 
 
The fibrillar organizations in cornea and tendon are vastly different although the 
tissues contain collagens I and V as their major collagenous components. Mature 
cornea consists of orthogonally stacked lamellae formed by uniformly thin collagen 
fibrils evenly spaced in parallel. Mature tendons contain fibrils with heterogeneous 
diameters arranged into parallel fibrous bundles. In both tissues, collagens must be 
cross-linked to exhibit the normal physical properties. However, they show distinctive 
patterns of cross-linking chemistry. In the extracellular matrix (ECM), cross-linking 
can result from the enzymatic activity of lysyl oxidase (LOX) and tissue 
transglutaminase (TG). In this present study, the relationship between tissue-specific 
fibril formation and cross-links in the ECM of chicken embryonic cornea and tendon 
has been investigated. 
 
Here, we have studied the suprastructural organization of matrices deposited by 
keratocytes and tenocytes cultures with or without cross-link formation by 
transmission electron microscopy. Fibril diameter distribution has also been 
analyzed. In addition, in-vitro fibrillogenesis with corneal collagen mixtures with and 
without activated TG were investigated by turbidity measurements and analysis of 
reconstitution products by electron microscopy. Furthermore, in cell culture 
experiments LOX-activity was measured by a tritium-release assay and TG-activity 
by addition of fluorescent-labeled cadaverine. Keratocyte cultures were metabolic 
labeled with 14C-proline for the characterization of cross-links. Some matrix-involved 
components were investigated with immunofluorescence labeling. 
 
We found that typical sheets of orthogonally arranged collagen fibrils were formed by 
keratocyte cell cultures. Such lamellae were not apparent when aldehyde-derived 
cross-link formation was inhibited. On the other hand, the organization of parallel-
arranged fibrils in tenocyte cell cultures also depends on the aldehyde-derived cross-
links. These observations suggested that the formation of cross-links is crucial for the 
tissue-specific matrix organization in chicken cornea and tendon. Further studies on 
keratocyte cultures showed that the orthogonal arrangement of fibrils was not 
strongly affected with the TG inhibitor. However, the collagen fibrils formed were 
thicker with a clearly visible banding pattern. Interestingly, the presence of both 
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cross-link leads to striking effects on matrix formation visible by loss of matrix 
organization and an irregular fibril diameter distribution. We also found in our in-vitro 
experiments that fibrils reconstituted from soluble corneal collagens were thinner and 
formed networks in the presence of activated TG and proteoglycan components. 
Such networks were absent in controls without TG. We presume that the stabilization 
of aggregates formed early is essential for the formation of the typical matrix 
organization of chicken cornea. Moreover, it has been shown that the deposition of 
decorin into matrix seemed to be delayed when cross-link formation was inhibited.  
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2 INTRODUCTIONS 
 
2.1 COLLAGEN 
Collagens are ECM-components and the most abundant proteins in mammals. 
Collagens play structural roles and contribute to the molecular architecture, shape, 
and mechanical properties of tissue such as the tensile strength in skin and the 
resistance to traction in ligaments (Kadler, 1995, Ricard-Blum et al., 2000). 
Furthermore, collagens interact with cells through several receptor families and 
regulate the cell growth, differentiation and migration. 
 
All members of the collagen family comprise three polypeptide α-chains and contain 
at least one domain composed of repeating Gly-X-Y sequences in each chain. In 
some collagens all three α-chains are identical (homotrimers) while in other 
collagens, there are two or three different chains (heterotrimers). Each of the three α-
chains within the molecule coiled into a left-handed helix with a pitch of 3 amino acids 
per turn (Hofmann et al., 1978), are then super coiled around a central axis in a right-
handed manner to form a triple helix (Fraser et al., 1979). The smallest amino acid, 
the glycine residue, in every third position of the polypeptide chains, is a structural 
prerequisite for the assembly into a triple helix. The X and Y position can be occupied 
by any amino acid, but often is proline and hydroxyproline, respectively (van der Rest 
and Garrone, 1991). In the triple-helix structure all glycine residue are positioned in 
the center while the more bulky side chains of other amino acids occupy the outer 
positions on the surface of the molecule. This allows a close packaging along the 
central axis of the molecule, polymerization of collagens per self-assembly into 
precisely structures. Therefore, the triple helix is rigid and this conformation is 
important for the biological properties of collagens.  
 
The collagen superfamily comprises 28 different collagen types in vertebrates (I-
XXVIII). There are also other proteins containing triple-helical domains such as the 
subcomponent C1q of complement, mannose-binding protein C, three macrophage 
receptors (MARCO), acetyl-choline esterase, and three ficolins. Based on their 
structure and supramolecular organization, collagens can be divided into several 
subfamilies: fibril-forming collagens, fibril-associated collagens with interrupted triple 
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helices (FACIT), network-forming collagens, membrane collagens, multiplexing, and 
others with unique functions.  
Collagens I-XXVIII have been reviewed according to α-chains and molecular species 
(Table. 2-1). The different collagen types are characterized by their structural 
diversity, variants of non-helical domains, assembly and functions. The domain 
composition and structural organization of different collagen types are listed in figure 
2-1. The fibril-forming collagens are rod-like collagens with a large triple helical 
domain (approximately 300 nm). These collagens co-assemble into banded fibrils in 
tissues including bone, dentin, tendons, cartilage, dermis, sclera, cornea, and the 
interstitial connective tissues in and around many organs (Birk and Bruckner, 2005). 
Collagen fibrils are made of collagens II, XI and IX in cartilage, of collagens I, III and 
V in skin (Keene et al., 1997), and of collagens I and V in cornea (Bruckner, 2010). 
Furthermore, collagen fibrils can be considered as macromolecular alloys of 
collagens and non-collagenous proteins or proteoglycans. Collagen XXIV is a novel 
collagen with structural features of invertebrate collagens (Koch et al., 2003). The α1-
chain of collagen XXIV contains an amino-terminal domain closely related to those of 
the types V and XI collagen subunits. Collagen XXVII forms thin nonstriated fibrils (10 
nm in diameter) that are distinct from the classical collagen fibrils (Plumb et al., 
2007).  
 
The FACITs do not form fibrils by themselves, but they are associated to the surface 
of collagen fibrils. Collagen IX is covalently linked to the surface of cartilage collagen 
fibrils mostly containing collagen II (Olsen et al., 1997), and collagens XII and XIV are 
associated to collagen I-containing fibrils. They can be integral parts and important 
organizers of the overall fibril structure rather than optional additions to preexisting 
aggregates (Birk and Bruckner, 2005). Collagen IV, with a more flexible triple helix, is 
the most important structural component of basement membranes integrating 
laminins, nidogens and other components into 2-dimensional supramolecular 
aggregate. The collagen VI microfibril is highly disulfide cross-linked and contributes 
to a network of beaded filaments interwoven with other collagen fibrils (von der Mark 
et al., 1984). Collagen X and VIII are both structurally related short-chain collagens 
and assemble to form hexagonal networks in tissues (Kühn, 1986; Sawada et al., 
1990; Yamaguchi et al., 1991). Types XIII, XVII, XXIII, and XXV collagens are 
transmembrane collagens which contain a single-pass hydrophobic transmembrane 
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domain (for review see Peltonen et al., 1999; Hashimoto et al., 2002; Banyard et al., 
2003; Franzke et al., 2003). 
Corresponding to the high diversity of the collagen superfamily, some genetic and 
acquired diseases of collagens have been discovered. Several autoimmune 
disorders involve autoantibodies directed against collagens, such as epidermolysis 
bullosa acquisita (Ishii et al., 2010), skin blistering disease bullous pemphigoid 
(Franzke et al., 2005), Goodpasture syndrome (Khoshnoodi et al., 2008) and 
Bronchiolitis obliterans syndrome (Burlingham et al., 2007). Otherwise, many 
disorders are caused by mutations in the genes coding for collagen α-chains, is listed 
in the human collagen mutation database (Dalgleish, 1998), COLdb database 
(Bodian and Klein, 2009) and osteogenesis imperfecte (Marini et al., 2007). The 
mutations affect the ECM by decreasing the amount of secreted collagen(s), 
impairing molecular and supramolecular assembly through the secretion of mutant 
collagens, or by inducing endoplasmic reticulum stress and the unfolded protein 
response (Bateman et al., 2009). 
 
Table 2-1.The collagen family (reviewed by Ricard-Blum, 2011). 
Collagen type Α Chains Molecular species 
Collagen I α1(I), α2(I) [α1(I)]2, α2(I) 
[α1(I)]3 
Collagen II α1(II) [α1(II)]3 
Collagen III α1(III) [α1(III)]3 
Collagen IV α1(IV), α2(IV), α3(IV), α4(IV), 
α5(IV), α6(IV) 
[α1(IV)]2, α2(IV) 
α3(IV)α4(IV)α5(IV) 
[α5(IV)]2, α6(IV) 
Collagen V α1(V), α2(V), α3(V), α4(V)a [α1(V)]2, α2(V) 
[α1(V)]3 
[α1(V)]2, α4(V) 
α1(XI)α1(V)α3(XI) 
Collagen VI α1(VI), α2(VI), α3(VI), α4(VI)b, 
α5(VI)c, α6(VI) 
 
Collagen VII α1(VII) [α1(VII)]3 
Collagen VIII α1(VIII) [α1(VIII)]2, α2(VIII) 
α1(VIII), [α2(VIII)]2 
[α1(VIII)]3 
[α2(VIII)]3 
Collagen IXe α1(IX), α2(IX), α3(IX) α1(IX), α2(IX), α3(IX) 
Collagen X α1(X) [α1(X)]3 
Collagen XI α1(XI), α2(XI), α3(XI)d α1(XI)α2(XI)α3(XI) 
α1(XI)α1(V)α3(XI) 
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Collagen XIIe α1(XII) [α1(XII)]3 
Collagen XIII α1(XIII) [α1(XIII)]3 
Collagen XIVe α1(XIV) [α1(XIV)]3 
Collagen XV α1(XV) [α1(XV)]3 
Collagen XVIe α1(XVI) [α1(XVI)]3 
Collagen XVII α1(XVII) [α1(XVII)]3 
Collagen XVIII α1(XVIII) [α1(XVIII)]3 
Collagen XIXe α1(XIX) [α1(XIX)]3 
Collagen XXe α1(XX) [α1(XX)]3 
Collagen XXIe α1(XXI) [α1(XXI)]3 
Collagen XXIIe α1(XXII) [α1(XXII)]3 
Collagen XXIII α1(XXIII) [α1(XXIII)]3 
Collagen XXIV α1(XXIV) [α1(XXIV)]3 
Collagen XXV α1(XXV) [α1(XXV)]3 
Collagen XXVI α1(XXVI) [α1(XXVI)]3 
Collagen XXVII α1(XXVII) [α1(XXVII)]3 
Collagen XXVIII α1(XXVIII) [α1(XXVIII)]3 
Individual α chains, molecular species, and supramolecular assemblies of collagen types. 
aThe α4(V) chain is solely synthesized by Schwann cells; bThe α4(VI) chain does not exist in humans; cThe α5(VI) has been 
designated as α1(XXIX); dThe α3(XI) chain has the same sequence as the α1(II) chain but differs in its posttranslational 
processing and cross-linking; eFACIT, Fibril-Associated Collagens with Interrupted Triple helices. 
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Figure 2-1.  Domain composition and supramolecular assemblies of collagens. COL: 
Collagenous, triple-helical, domains; NC: Non-collagenous, nontriple-helical, domains. They 
are numbered from the carboxy- to the amino-terminus, except for collagen VII (reviewed by 
Ricard-Blum, 2011). 
 
2.2 FIBRIL-FORMING COLLAGENS AND FIBRIL FORMATION  
The classical fibril-forming collagens include collagen types I, II, III, V, and XI. 
Procollagen chains are synthesized in the endoplasmic reticulum (ER), are brought 
together by interactions between the C-propeptides and fold to form a rod-like triple-
helical domain flanked by globular N- and C-propeptides. The C-propeptides play an 
important role in procollagen folding because they ensure association between 
monomeric procollagen chains and determine chain selectivity (Bulleid et al., 1997; 
Lees et al., 1997). Association between procollagen chains is preceeded by folding 
and disulphide bond formation within the individual C-propeptides (Doege and 
Fessler, 1986). A large number of post-translational modifications then occur in the 
ER, in which a number of enzymes and molecular chaperones assist the folding and 
trimerization of procollagen, such as the protein disulphide isomerase (PDI) (Bulleid 
et al., 1996), peptidylproline cis-trans isomerase (PPI) (Galat et al., 1995; Bachinger 
et al., 1987; Davis et al., 1989), prolyl-4-hydroxylase (P4H) (Kivirikko and Myllyharju, 
1998; Myllyharju, 2003), prolyl-3-hydroxylase (Vranka et al., 2004), a family of lysyl 
hydroxylases (Kellokumpu et al., 1994; Valtavaara et al., 1998; Wang et al., 2002) 
and the collagen-specific chaperone HSP47 (Nagata, 1998 and 2003). Removal of 
INTRODUCTION 
	   15	  
the N- and C-propeptides from fully folded procollagen by the procollagen N- and C-
proteinases (Leung et al., 1979) occurs partly after transport of procollagen across 
the Golgi stacks in ECM and partly inside tendon fibroblasts (Canty et al., 2004). The 
resulting collagen molecules are then able to assemble into fibrils. Covalent 
crosslinks occur within and between triple-helical collagen molecules in fibrils. An 
overview of the fibril formation by fibroblasts was in figure 2-2 illustrated. 
 
 
Figure 2-2. Overview of the steps involved in the production of collagen fibrils by fibroblasts 
(Canty and Kadler, 2005). 
 
Collagen molecules are arranged in longitudinally staggered arrays resulting a tissue-
specific length of staggers between adjacent fibrillar collagen molecules. Therefore, a 
gap occurs sequentially between neighboring molecules giving rise to a gap-overlap 
structure in the collagen fibrils to represent a banding pattern with a periodicity (D-
period) of 64-67 nm (Birk and Bruckner, 2005; Bruckner, 2010). Collagen fibrils range 
in diameter from approximately 15 nm up to 500 nm or more depending on the tissue 
type (Kadler et al., 2007; Bruckner, 2010). The structure of a generic collagen fibril is 
illustrated in figure 2-3. 
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Figure 2-3. Structure of a generic collagen fibril. A D-periodic collagen fibril from tendon is 
presented at the top of the panel. The negative stained fibril has a characteristic alternating 
light/dark pattern representing the gap (dark) and overlap (light) regions of the fibril. The 
diagram represents the staggered pattern of collagen molecules giving rise to this D-periodic 
repeat. The collagen molecules (arrows) are staggered N to C. The fibrillar collagen molecule 
is approximately 300 nm (4.4 D) in length and 1.5 nm in diameter (Birk and Bruckner, 2005). 
 
2.3 MOLECULAR CONSTITUENTS OF CORNEA  
2.3.1 Collagens 
2.3.1.1 Type I collagen  
Type I collagen is the most abundant fibrillar collagen. It forms more than 90% of the 
organic mass of bone and is the major collagen of tendons, skin, ligaments, cornea, 
and many interstitial connective tissues with the exception of very few tissues such 
as hyaline cartilage, brain, and vitreous body. The collagen I triple helix is usually 
formed as a heterotrimer [α1(I)]2α2(I). In vivo the triple helix are mostly incorporated 
into composite fibres containing either type III collagen in skin and reticular fibres 
(Fleischmajer et al., 1990) or type V collagen in cornea, bone and tendon (Niyibizi et 
al., 1989). In most organs collagen I provides tensile stiffness and load bearing. 
However, the homotrimers consisting of three α1(I) chains, [α1(I)3] (Bornstein and 
Sage, 1980; Deak et al., 1983; Kadler et al., 2007; Kielty et al., 1993) have been 
shown to be present during embryogenesis (Jimenez et al., 1977), in tumors (Moro 
and Smith, 1977; Rupard et al., 1988; Makareeva et al., 2010), fibrotic tissues 
(Rojkind et al., 1979; Narayanan et al., 1980; Ehrlich et al., 1982; Philips et al., 2002) 
and in stressed mesangial cells (Haralson et al., 1987). Recent finding revealed that 
the type I collagen homotrimers are much more resistant to degradation by matrix 
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metalloproteinase (MMPs) than the heterotrimers (Makareeva et al., 2010; Han et al., 
2010). 
 
2.3.1.2 Type V collagen  
Type V collagen is a quantitatively minor fibrillar collagen present in tissues where 
type I collagen is expressed. There are several type V collagen isoforms that differ in 
chain composition. The most common isoform found in cornea is [α1(V)]2α2(V) (Birk 
et al., 1988; Birk and Linsenmayer, 1994). The native, completely-processed type V 
collagen molecule, as extracted from tissues, retains a large pepsin-sensitive, 
globular domain at the NH2-terminal end of its α1(V) chain (Bächinger et al., 1982; 
Broek et al., 1985; Fessler et al., 1985, 1987; Kumamoto et al; 1981). When co-
assembled along with type I collagen into heterotypic fibrils, collagen V serves to 
regulate fibril diameter via partially processed NH2-terminal globular sequences. 
Because of the high content (15-20% of the fibrillar collagens) of corneal collagen 
fibrils, collagen V is considered to be responsible for the thin, uniform diameter (Birk 
et al., 1990; Marchant et al., 1996). However, an [α1(V)]3 homotrimer as well as an 
[α1(V)α2(V)α3(V)] form have been reported in human placenta (Sage and Bornstein, 
1979; Madri et al., 1982; Niyibizi et al., 1984). Type V collagen α chains also form 
heterotypic molecules with type XI collagen α chains. The α1(V) and α2(V) has been 
detected additionally to α1(XI) in bovine bone (Niyibizi and Eyre, 1989), whereas, in 
the bovine vitreous, the α2(V) coexist with the α1(XI) chain (Mayne et al., 1993). The 
formation of heterotypic [α1(XI)]2α2(V) molecules were demonstrated to occur in the 
human rhabdomyosarcoma cell line A204 (Kleman et al., 1992). A novel α4(V) chain 
is solely synthesized by Schwann cells and the α4(V)-collagen exhibits particular high 
affinity for the heparan sulfate transmembrane proteoglycan syndecan-3 via a 
heparin binding site located in the variable region of the N-propeptide (Mechanic et 
al., 1987). 
 
2.3.1.3 Type VI collagen  
Type VI collagen is a nonfibrillar collagen present as a network throughout many 
tissues including the chick embryo secondary corneal stroma. It is initially defined as 
a large collagenous glycoprotein composed of three different α-chains, the α1(VI), 
α2(VI), and α3(VI) chains (Kielty et al., 2002; Chu et al., 1987). Collagen VI 
monomers have a relatively short triple helical domain flanked by N- and C-terminal 
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globular domains which contain varying numbers of “von Willebrand type A repeats” 
(VWA). The structural heterogeneity of collagen VI is introduced by alternative 
splicing of domains, primarily of the α3(VI) N-terminal domain containing a maximum 
of ten type A repeats. It is now known that three additional chains, 
α4(VI),α5(VI),α6(VI), exist in mouse. All three are similar to the α3(VI) chain. 
Orthologs of α5(VI) and α6(VI) have been found in human (Fitzgerald et al., 2008; 
Gara et al., 2008). The α4 chain forms trimers far more frequently than the α5 and α6 
chains in mouse whereas it does not exist in humans. In human the α5 is equivalent 
to the α4 in mouse (Gordon, 2010). 
 
Collagen VI has a ubiquitous distribution in connective tissues. The assembly of 
collagen VI monomers is initiated in the lumen of intracellular compartments. 
Tetramers are secreted and are the building blocks that assemble extracellularly into 
the tissue forms of type VI collagen. In the ECM, tetramers associate end-to-end 
forming beaded filaments, which laterally associate to form beaded microfibrils 
(Bruns et al., 1986; Furthmayr et al., 1983; Baldock et al., 2003).  
 
Collagen VI interacts with a large number of ECM molecules including collagen I, II, 
IV, XIV, microfibril-associated glycoprotein (MAGP-1), perlecan, decorin, biglycan, 
hyaluronan, heparin and fibronectin as well as integrins and the cell-surface 
proteoglycan NG2. Supramolecular aggregates of collagen VI are composite 
structures with other integrated molecules modulating the functional properties of the 
collagen VI-containing suprastructure (Birk and Bruckner, 2005). Studies on corneal 
fibroblasts showed that collagen VI is associated with cells and between striated 
fibrils forming a network around fibrils and close to corneal fibroblasts (Doane et al., 
1992). It was suggested that type VI collagen plays a role in cell-matrix interactions 
during corneal stroma development. 
 
2.3.2 Keratin 
Keratins are a group of water-insoluble proteins that form 10 nm intermediate 
filaments in all epithelial cells. Approximately 30 different keratin molecules have 
been identified (Moll et al., 1982; Cooper et al., 1996), with a range of molecular 
masses between 40 and 80 kDa (Franke et al., 1981). The keratins can be divided 
into two subfamilies: the acidic or type I and the basic or type II (Schiller et al., 1982). 
INTRODUCTION 
	   19	  
Each acidic keratin is preferentially co-expressed with a particular basic keratin, 
forming a keratin pair. Different pairs are expressed in a tissue-specific, 
differentiation-related and developmentally regulated fashion (Kurpakus et al., 1992; 
Liu et al., 1993; Moll et al., 1982; Fuchs et al., 1978). Expression of the keratin 
3/keratin 12 pair has been found in human, bovine, guinea pig, rabbit, and chicken 
cornea and is regarded as a biochemical marker for an advanced stage of “corneal-
type” epithelial differentiation (Cooper et al., 1996; Chaloin-Dufau et al., 1990; 
Schermer et al., 1986; Sun et al., 1984). 
 
2.3.3 Fibronectin 
Fibronectin (FN) is a ubiquitous component of the ECM and has been well 
characterized as an ECM glycoprotein that can regulate many cellular functions such 
as proliferation, differentiation, migration, adhesion and apoptosis (Pankov and 
Yamada, 2002; Magnusson and Mosher, 1998; Wierzbicka-Patynowski and 
Schwarzbauer, 2003; Mosher, 1989; Hynes, 1990). FN is secreted as a large dimeric 
glycoprotein with subunits that range in size from 230-270 kDa depending primarily 
on alternative splicing (Hynes, 1990; Mosher, 1989). It was categorized as either 
soluble plasma FN (pFN) or insoluble cellular FN (cFN) (Pankow and Yamada, 2002; 
ffrench-Constant, 1995; Kosmehl et al., 1996). The cellular FN is the major form and 
abundant in the fibrillar matrices of most tissues. FN is composed of three different 
types of modules termed type I, II and III repeats (Petersen et al., 1983; Hynes, 
1990). The domain organization and isoforms of FN were reviewed in Figure 2-4. 
 
                
 
Figure 2-4. Fibronectin (FN) domain organization and isoforms. Each FN monomer has a 
modular structure consisting of 12 type I repeats (cylinders), 2 type II repeats (diamonds), 
and 15 constitutive type III repeats (hexagons). Two additional type III repeats (EIIIA and 
EIIIB, green) are included or omitted by alternative splicing. The third region of alternative 
splicing, the Vregion (green box), is included (V120), excluded (V0), or partially included 
(V95, V64, V89). Sets of modules comprise domains for binding to other extracellular 
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molecules as indicated. Domains that are required for fibrillogenesis in red: the assembly 
domain (repeats I1-5) binds FN, III9-10 contains the RGD and synergy sequences for integrin 
binding, and the carboxy-terminal cysteines for the disulfide bonded FN dimer ( ). The III1-2 
domain (light red) has two FN binding sites that are important for fibrillogenesis. The amino-
terminal 70 kDa fragment contains assembly and gelatin-binding domains and is routinely 
used in FN binding and matrix assembly studies (Schwarzbauer and DeSimone, 2011). 
 
FN accomplishes diverse functions through interactions with a large variety of 
proteins including collagens, fibrin, cell surface integrins, heparan sulfate 
proteoglycans, and tenascin-C. In tissues, activated FN is deposited and organized 
into a polymeric matrix which is associated with collagen fibers. FN matrix was 
proposed to act as a scaffold to regulate the deposition and assembly of type I and III 
collagens (Velling et al., 2002; Sottile et al., 2002). In the context of the findings of 
the most performed in this PhD-project, the following observations are of particular 
interest. It has been demonstrated previously that lysyl oxidase (LOX) has a high 
binding affinity for cellular FN. FN acts as a scaffold for enzymatically active 30-kDa 
LOX. The co-localization of LOX and FN in cultured fibroblasts and normal human 
tissues has been revealed. Additionally, the proteolytic activation of LOX is much 
reduced in cultures of FN-null mouse embryo fibroblasts (Fogelgren et al., 2005). A 
recent study showed that FN binds bone morphogenetic protein-1 like (BMP1-like) 
proteinases in vivo and it is an important determinant of the in vivo activity levels of 
BMP1-like proteinases (Huang et al., 2009). This conclusion implies a crucial regular 
function of FN on LOX activity because BMP1 is required for LOX activation. As fibrin 
polymerizes, factor XIII transglutaminase covalently cross-links glutamine residues 
near the amino terminus of FN to fibrin α chains (Corbett et al., 1997; Mosher, 1975). 
The gelatin/collagen-binding domain, which composed of type I and II modules, binds 
to tissue transglutaminase (Radek et al., 1993) and fibrillin-1 (Sabatier et al., 2009).  
 
2.3.4 Decorin 
Decorin, a member of a family of proteins with leucine-rich repeat (LRR) motifs, is a 
ubiquitous small ECM proteoglycan. It is composed of a ~40 kDa core protein 
containing 10 leucine-rich-repeats flanked by cysteine loops on both sides and 
contains N-linked glycosylation sites (Krusius and Ruoslahti, 1986) (Fig. 2-5). 
Furthermore, at the N-terminus decorin is covalently linked with a glycosaminoglycan 
(GAG) chain of chondroitin/dermatan sulfate type depending on the tissue in which it 
is expressed (Seidler and Dreier, 2008). 
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Figure 2-5. Domain structure of the decorin protein core. From N- to C-terminus: signal 
peptide (SP); propeptide (PP); the glycosaminoglycan attachment site at a serine residue in 
the N-terminal Cys-rich domain; central LRR repeats; C-terminal Cys-rich domain. There are 
3 N-linked oligosaccharide attachment sites in the LRR domains (Chen and Birk, 2011). 
 
Decorin is thought to be responsible for the structure, tissue organization and surface 
properties of fibrils. It was shown to associate with collagen fibrils in a number of 
connective tissues (Pringle et al., 1990; Fleischmajer et al., 1991; Scott et al., 1992). 
It was given the name decorin since it decorates the surface of fibrils at the “d” and 
“e” bands with its GAGs extending into the interfibrillar space (Pringle and Dodd, 
1990). Decorin binds to collagens I and II via its core protein and inhibits collagen 
fibril formation in vitro (Vogel et al., 1984; Hedbom et al., 1989). The influence of 
decorin on collagen I fibrillogenesis in vitro was assigned to a delayed initial 
assembly of collagen molecules and a decreased fibril diameter (Vogel and Trotter, 
1987). This interaction occurs mainly via the leucine-rich repeats 4-5 of the decorin 
core protein (Svensson el al., 1995). Furthermore, decorin bridges type VI collagen 
filaments to fibrils (Bidanset et al., 1992) and also acts as a bridging molecule 
between type I and type VI collagen, interacting with them via different binding sites 
(Nareyeck et al., 2004). In addition, decorin interacts with collagen types XII and XIV 
through its GAG chains and mediates the interaction of tenascin with collagen (Font 
et al., 1993, 1996). All of these interactions are possibly involved in the corneal 
stroma organization. In addition to the closely related class I small leucine-rich 
proteoglycan (SLRP), biglycan, data indicate that decorin is the dominant corneal 
class I SLRP and a major regulator of corneal fibrillogenesis (Zhang el al., 2009). 
 
Decorin has also multiple non-structural functions: it binds to growth factors such as 
TGF-ß and FGF-2, and sequesters them in the ECM or presents them to receptors. It 
also modulates the TGF-ß signal pathway through the LRP1 receptor, inhibiting cell 
growth and increasing ECM deposition (Winnemoller et al., 1992). Moreover, decorin 
binds fibronectin and thrombospondin modulating cell adhesion and migration 
(Hildebrand et al., 1994; Iozzo et al., 1999). Also, decorin can modulates cell 
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immunity via binding of the complement, factor C1q, scavenger receptor-A or 
surfactant-associated protein-D. These interactions are consistent with decorin´s 
involvement in diverse pathological processes (Schaefer and Iozzo, 2008). 
 
2.3.5 Hydroxyproline 
Hydroxyproline is a non-proteinogenic amino acid, which is produced by post-
translational hydroxylation of the amino acid proline. In contrast to other mammalian 
proteins, collagen contains a high concentration of hydroxyproline, which is thought 
to be confined exclusively to the connective tissue seleroproteins, collagen and 
elastin (Gross and Piez, 1960). Therefore, hydroxyproline has been widely used as 
an indicator of both the presence and the metabolism of collagen. 
 
2.4 COLLAGEN CROSS-LINKING 
Collagens must be cross-linked to exhibit the normal physical properties of tensile 
strength and different tissue types showed distinctive pattern of cross-linking 
chemistry. ECM cross-linking can result from the enzymatic activity of lysyl oxidase, 
tissue transglutaminase (Aeschlimann and Paulsson, 1991), or nonenzymatic 
glycation (Girton et al., 1999). 
 
2.4.1 Lysyl oxidase 
Lysyl oxidase (LOX) is a copper-dependent amine oxidase. It is responsible for the 
oxidative deamination of key lysine residues in collagen and elastin prior to cross-link 
formation, and plays a pivotal role in the formation of a stable, insoluble ECM. LOX 
catalyzes the formation of ε-aldehydes in collagen and elastin from certain lysyl and 
hydroxylysyl residues (Siegel and Martin, 1970; Rodriguez et al., 2008) (Figure 2-6). 
These aldehydes, allysine and hydroxyallysine, are intermediates in formation of 
intra- and intermolecular cross-links. The LOX-catalyzed crosslinks occur in various 
connective tissues within the body, including bone, cartilage, skin, lung etc., and are 
believed to be a major source of mechanical strength in tissues. LOX is secreted 
from fibrogenic cells as a 50 kDa, N-glycosylated pro-enzyme, and is processed in 
the extracellular environment to produce the active, mature 32-kDa enzyme and an 
18 kD propeptide (Trackman et al., 1992). The pathway of LOX synthesis and its 
intra- and extracellular functions are illustrated in figure 2-7. The sequence of the 
proteolytic processing site in pro-lysyl oxidase resembles that of the fibrillar 
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procollagen C-terminal pro-peptide processing sites cleaved by procollagen C-
proteinase (PCP) (Cronshaw et. al., 1995), whose activity is provided by products of 
the bmp1 (Bone Morphogenetic Protein 1) gene (Kessler et al., 1996). Moreover, 
preparations highly enriched in PCP activity have been shown to process pro-lysyl 
oxidase at the correct physiological site (Panchenko et al., 1996). 
 
                      
 
Figure 2-6. Reaction catalysed by lysyl oxidase (LOX). LOX oxidizes primary amines on 
collagen and elastin substrates to reactive semialdehydes that condense to form covalent 
cross-linkages (Rodriguez et al., 2008). 
 
 
                    
 
 
Figure 2-7. Lysyl oxidase (LOX) synthesis and intra- and extracellular functions. LOX is 
synthesized as a pre-protein, and after signal peptide hydrolysis, enzyme glycosylation, 
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copper incorporation, and lysine tyrosylquinone (LTQ) generation, the enzyme is released 
into the extracellular space (1). Then, BMP-1 processes LOX yielding the mature LOX form 
and its pro-peptide. Whereas LOX participates in ECM stabilization, its propeptide induces 
phenotypic reversion of ras-transformed cells. Extracellular LOX could translocate from the 
extracellular environment to intracellular compartments (2). In tumour breast cells, cytosolic 
LOX controls cell adhesion and motility (3). Nuclear forms of lysyl oxidase control gene 
expression (4). Histones H1 and H2 could be nuclear substrates of this enzyme (Rodriguez 
et al., 2008). 
 
Transforming growth factor-ß (TGF-ß), platelet-derived growth factor, angiotensin II, 
retinoic acid, fibroblast growth factor, altered serum conditions, and shear stress is 
among the effectors or conditions that regulate LOX expression. Besides its role in 
connective tissues, LOX enzyme promotes growth, migration, invasion and 
metastasis of tumor cells, especially in response to hypoxia (Erler et al., 2006). 
Moreover, LOX has also been involved in non-tumoral processes, including the 
control of cell adhesion, gene regulation (Giampuzzi et al., 2003) and differentiation, 
within various cell types such as osteoblasts, adipocytes and keratinocytes (Huang et 
al., 2009). 
 
The lysyl oxidase gene family comprises five members acting as extracellular 
modulating enzymes: LOX, LOXL1, LOXL2, LOXL3 and LOXL4. The LOXL1-4 (lysyl 
oxidase like proteins) have significant sequence identity with mature LOX, but have 
no similarity to the propeptide region of LOX (Csiszar et al., 2001). The first identified 
isoform is LOX. LOX activity modulation induces multiple effects on the structure and 
major characteristics of the ECM. For example, LOX is essential in maintaining the 
characteristics of blood vessels and arteries (Rodriguez et al., 2002). The down-
regulation of LOX is correlated to many connective tissue disorders seen in Ehler-
Danlos syndrome (Kuivaniemi et al., 1985), cutis laxa (Khakoo et al., 1997), and 
Menke´s syndrome (Pinnel et al., 1982). In tumors, LOX up-regulation is found in the 
stromal reaction observed around tumor foci in ductal breast carcinomas and in 
bronchopulmonary carcinomas (Peyrol et al., 2000). LOX-null animals die late in 
gestation or soon after birth and exhibit a wide range of connective tissue 
abnormalities (Maki et al., 2002; Hornstra et al., 2003). 
 
LOX activity was originally detected by a tritium release assay in which chick aorta 
elastin labeled with [6-3H]lysine in organ culture was used as a substrate (Pinnell and 
Martin, 1968) (Fig. 2-8). Tritium was released as aldehydes formed under the 
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influence of LOX. This reaction was inhibited by micromolar concentrations of β-
aminopropionitrile (ßAPN). It has been mentioned that LOX activity with collagen 
substrates was significantly increased when collagen was precipitated from solution 
as reconstituted fibrils (Siegel et al., 1974). It also has been shown that the enzyme 
binds to the triple-helical portion of collagen melecules and binds predominantly to 
the fibrillar surface. Other data indicated that LOX initiates crosslink formation at an 
early stage in collagen fibrillogenesis (Cronlund et al., 1985). 
 
                       
 
Figure 2-8. Measurement of LOX activity: release of tritium during allysine formation (Pinnell 
and Martin, 1968). 
 
The β-aminopropionitrile (ßAPN) (Fig. 2-9) was initially found and identified in 
Lathyrus odoratus peas and it caused osteolathyrism in sheep (Geiger et al., 1933; 
McKay et al., 1954). In 1961 it was understood that ßAPN inhibited collagen and 
elastin cross-linking in some way (Martin et al., 1961); and Pinnell and Martin later 
reported that ßAPN inhibited an enzyme that catalyzed oxidative deamination of 
lysine residues in elastin, and named it lysyl oxidase (Pinnell and Martin, 1968). 
 
                                          
 
Figure 2-9. Chemical structure of β-aminopropionitrile. 
 
2.4.2 Tissue transglutaminase 
Tissue transglutaminase (TG), also known as TG2, belongs to a family of structurally 
and functionally related enzymes (Aeschlimann et al., 1994) which catalyze Ca2+-
dependent acyl-transfer reactions between the γ-carboxamide group of specific 
peptide-bound glutamine residues and primary amines, including the ε-amino group 
of peptide-bound lysine. These reactions lead to the formation of the γ-glutamyl-ε-
lysine cross-link which is stable and resistant to proteolysis, thereby increasing the 
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resistance of tissue to chemical, enzymatic and mechanical disruption. TG catalyzed 
cross-linking is a physiological mechanism for the stabilization of basement 
membranes and cartilage matrix (Aeschlimann et al., 1994; 1995). Several collagen 
types (II, V/XI, VII, the N-propeptide of procollagen III) and a number of other 
extracellular proteins (fibronectin, nidogen, osteonectin, osteopontin, vitronectin and 
microfibril associated glycoprotein) are glutaminyl substrates of TG in vitro and/or in 
vivo (reviewed in Aeschlimann et al., 1994; Brown-Augsburger et al., 1994; Kleman 
et al., 1995; Raghunath et al., 1996). There are currently eight described 
transglutaminase enzymes in mammals, all of them require Ca2+ for activity, some 
also require proteolytic cleavage of propeptides, and three of them (TG2, TG3 and 
TG5) are inhibited by GTP (R.J. Collighan and M. Griffin, 2009). In vertebrates nine 
evolutionary related genes have evolved: encoding blood coagulation Factor XIII-a, 
TG1-7 and the inactive epb42 (Grenard et al., 2001). TG2 is predominantly a 
cytoplasmic protein, but it is also found in the nucleus and mitochondria, on the 
plasma membrane and the extracellular cell surface, and in the ECM (Park et al., 
2010). 
 
Due to low-GTP and high-calcium concentrations in the extracellular space, it is 
conceivable that extracellular TG2 is an active TGase. Data suggest that the TGase 
activity is involved in remodeling of the ECM under normal and pathological 
circumstances. Besides its classical protein cross-linking activity, TG2 possesses 
several other biochemical functions at various cellular locations (Fig. 2-10). It can 
function as a G protein (high-molecular weight GTP-binding protein) (Nakaoka et al., 
1994), also has protein disulfide isomerase (PDI) (Hasegawa et al., 2003), protein 
kinase (Mishra et al. 2007) and DNA nuclease activities (Takeuchi et al., 1998). This 
multifunctional protein is expressed ubiquitously and abundantly, and is implicated in 
a variety of cellular processes, such as differentiation, cell death, inflammation, cell 
migration, and wound healing (reviewed in Fesus and Piacentini, 2002; Lorand and 
Graham, 2003; Fesus and Szondy, 2005; Ientile et al., 2007; Collighan and Griffin, 
2009; Sarang et al., 2009). Beyond its functional diversity, TG2 has both pro-and 
anti-apoptotic functions (Fesus and Szondy, 2005). Although it has been initially 
studied as an intracellular enzyme, TG2 is secreted into the extracellular space or 
onto the cell surface (Verderio et al., 1998; Gaudry et al., 1999). Cell-surface TG2 is 
proposed to be an important tissue-stabilizing enzyme that is active during wound 
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healing (Haroon et al., 1999). Cell surface TG2 is also involved in cell adhesion via its 
tight interaction with fibronectin and the resultant intracellular signaling effects are 
reported to be mediated by various β1 and β3 integrins (Gaudry et al., 1999). Since 
the assembly of fibronectin is the initiator for a number of other ECM structures such 
as fibrillin1, TG2 has the potential to play a major role in initial assembly of the ECM, 
not just in modification of the existing ECM. TG2, once deposited into the matrix and 
in complex with fibronectin, can also bind to the heparan sulphate chains of 
syndecan 4 on the cell surface (Verderio et al., 2003). Therefore, TG2 may mediate 
cell-ECM interactions. 
 
             
 
Figure 2-10. Biochemical activities of TG2. TG2 catalyzes Ca2+-dependent acyl-transfer 
reaction between γ-carboxamide group of a specific protein-bound glutamine and either the 
ε-amino group of a distinct protein-bound lysine residue (covalent protein crosslinking; the 
principal in vivo activity) or primary amines such as polyamines and histamine. Water can 
replace amine donor substrates, leading to deamidation of the recognized glutamines. TG2, 
similar to factor XIIIa, has Ca2+-dependent isopeptidase activity and at least under test tube 
conditions, can hydrolyse γ:ε isopeptides. TG2 can be exposed on the external leaflet of the 
plasma membrane. The presence of TG2 outside the cell has been proposed to depend on 
its interaction with fibronectin and integrins. TG2 binds and thereby activates phospholipase 
C following stimulation of several kinds of cell surface receptors; its endogenous GTPase 
activity ensures proper regulation of transmembrane signalling through these receptors. 
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Functions of TG2 are performed in the cytosol (C), the nucleus (N), at the cell membrane (M) 
and in the extracellular space (E). Except for its isopeptidase activity, all other functions have 
been shown to occur in intact cells and/or tissues (Fesus and Piacentini, 2002). 
 
The Boc-DON-Gln-lle-Val-OMe, a synthetic modified polypeptide produced by 
ZEDIRA GmbH, is a potent, active site directed inhibitor of tissue transglutaminase 
(Fig. 2-11). The reaction results in an alkylation of active site cysteine which 
irreversibly inhibits the activity of TG2. It has been proven that this peptide showed a 
selective reaction with the cysteine residue in the active site of TG2. 
 
                                 
 
Figure 2-11. Chemical structure of Boc-DON-Gln-lle-Val-OMe. 
 
2.4.3 Factor XIII 
Factor XIII, also known as fibrin-stabilizing factor, is a plasma TGase, and circulates 
in blood as a pro-transglutaminase. It consists of two potentially active a- subunits 
and two inhibitor/carrier b-subunits. XIII-a is synthesized in cells of bone marrow 
origin, whereas XIII-b is produced in the liver by the hepatocytes. In normal 
conditions, all FXIII-a present in the plasma is in a complex, whereas FXIII-b is in 
excess, and about 50% of it circulates as a free, uncomplexed protein (Karimi et al., 
2009). The enzyme precursor factor XIII can be activated by thrombin and Ca2+ in the 
final phase of the clotting cascade. The activation that immediately follows fibrin 
formation is a process to unmask the active site of factor XIII-a, a ε-lysyl-γ-glutamyl 
aminoacyl transferase. It is capable of cross-linking a growing list of proteins, not only 
within plasma, but also proteins within the vascular matrix, platelets, endothelial cells 
and monocytes (Hsieh and Nugent, 2008). A number of other proteins are known to 
be substrates of factor XIII: plasminogen-activator inhibitor type-2, osteopontin, 
lipoprotein, platelet vinculin, factor V, thrombospondin, etc., are also reported to 
become substrates for activated XIII in vitro (Ichinose, 2005). 
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Accordingly, the main hemostatic functions of FXIII-A are to form fibrin γ-chain 
dimers, to cross-link its α-chains into high-molecular-weight polymers, and to attach 
α2 plasmin inhibitor to fibrin α-chains. In this process, FXIIIa mechanically stabilizes 
the fibrin clot and protects it from shear stresses and from the prompt degradation by 
the fibrinolytic system. A recent review provides further details on the key regulatory 
role of FXIII in fibrinolysis (Muszbek et al., 2008). In addition to the above functions, 
FXIII is also involved in wound healing (Duckert et al., 1960), angiogenesis (Dardik et 
al., 2006), and is essential for maintaining pregnancy (Koseki-Kuno et al., 2003). The 
enzyme promotes clot stability by forming covalent bonds between fibrin molecules 
and also by cross-linking fibrin with several proteins including α2-plasmin inhibitor, 
fibronectin, and collagen. These reactions lead to an increase in the mechanical 
strength, elasticity and resistance to degradation by plasmin of fibrin clots, and 
promotion of wound healing by providing a scaffold for fibroblasts to proliferate and 
spread. 
 
2.5 TISSUE-SPECIFIC FIBRIL ORGANIZATION  
The characteristics of different extracellular matrices are determined by the 
synthesis, assembly and deposition of collagen molecules and their organization into 
unique macromolecular structures. Fibrillar collagen molecules are organized into 
fibrils, which are organized into tissue-specific macroaggregates such as regular 
layers in cornea and bone, cables in tendon and ligaments, or irregular layers or 
wickerwork in dermis. At each level of this hierarchy the collagen fibrils have tissue 
specific characteristics, i.e. fibril diameter, packing and organization.  
 
2.5.1 Cornea 
The cornea is the transparent front part of the eye that comprises a highly structured, 
membrane bound, transparent collagenous tissue, which joins the more disorganized 
and opaque sclera at the limbus. The native cornea provides three fundamental 
functional attributes to the ocular optical system: protection, transmission and 
refraction of the incident light to the retina. It consists primarily of three layers: an 
outer layer containing an epithelium, a middle stromal layer consisting of a collagen-
rich ECM interspersed with keratocytes and an inner layer of endothelial cells (Fig. 2-
12). The Bowman’s membrane is a thin acellular matrix, which lies subjacent to the 
corneal epithelium and its basement membrane. It contains also fibrils thinner than 
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those of the stroma (Hay and Revel, 1969), and shows strong immunofluorescence 
for type V collagen without unmasking (Linsenmayer et al., 1983, 1984; Birk et al., 
1986). The Descemet’s membrane is a thin acellular layer that serves as the modified 
basement membrane of the corneal endothelium, is composed mainly of collagen 
type IV-containing networks. At the heart of the cornea is the stromal tissue that 
comprises 90% of the total thickness of cornea. As the major protein component of 
the stroma, collagens comprise 71% of the dry weight (Newsome et al., 1981). The 
corneal stroma is unique in having a homogeneous distribution of small diameter (25-
30 nm) fibrils that are regularly packed within orthogonal layers, called lamellae. This 
lattice-like structure produces minimal light scattering to provide transparency 
(Maurice, 1957; Benedek, 1971).  
 
                             
 
Figure 2-12. The left panel is a light micrograph of a developmentally mature cornea. The 
right panels are electron micrographs of portions of Bowman´s membrane (top), the stroma 
proper (middle), and Descemet´s membrane (bottom) (Linsenmayer et al., 1998). 
 
The ECM of the corneal stroma consists primarily of collagens with lesser amounts of 
proteoglycans. Type I collagen is the predominant collagen of the cornea, which 
assembles with collagen V (10-20% of the total collagen) to form heterotypic fibrils 
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(Birk et al., 1986). However, the heterotypic type I/V collagen fibrils of corneal stroma 
show different distribution of both collagen types within the fibrils. The triple helical 
domain of type I molecules occurs both within the fibril and at the fibril´s surface, 
whereas the triple helical domain of most type V collagen molecules is buried within 
the fibril´s interior. Moreover, type V molecules have a large NH2-terminal domain 
(globular domain derived from α1(V) chains) extending outwards through a gap zone 
to the fibril´s surface (Linsenmayer et al., 1993). These collagen I/V fibrils interact 
with FACIT collagens, type XII and/or XIV depending on developmental stage. In 
addition, the small leucine rich proteoglycans, decorin, lumican, biglycan, keratocan 
and osteoglycine interact with the fibril surface (Fig. 2-13) (Birk and Bruckner, 2005). 
 
                     
 
Figure 2-13. Corneal fibril: (A) corneal fibrils are heterotypic, co-assembled from collagens I 
and V. Collagen V is a quantitatively minor component of most collagen I-containing fibrils. It 
has a retained N-terminal, non-collagenous domain that must be in/on the gap region/fibril 
surface. The heterotypic interaction is involved in efficient initiation of fibril assembly; (B) the 
heterotypic alloy forms the core of a composite fibril with fibril-associated leucine-rich repeat 
proteoglycans and FACIT collagens bound to the surface. While the heterotypic composition 
is relatively constant, the fibril-associated macromolecules are more dynamic, changing 
temporally during development or repair and spatially in different tissues/tissue domains (Birk 
and Bruckner, 2005). 
 
2.5.2 Tendon  
Tendons are collagen-based fibrous tissues that connect and transmit forces from 
muscle to bone (Birk and Trelstad, 1986; Carvalho et al., 2000). They are composed 
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of closely packed parallel collagen fibre bundles, have high tensile strength and 
function to transmit forces and stabilize joint structures (Birk and Trelstad, 1986; 
Erksen et al., 2002; Edom-Vovard and Duprez, 2004). The fibril bundles together with 
the tendon fibroblasts are organized into fascicles, and the fascicles are bound 
together in a connective tissue sheath to form a tendon (Kastelic et al., 1978; Birk 
and Trelstad, 1986; Birk and Mayne, 1997; Birk et al., 1990) (Fig. 2-14). 
 
              
 
Figure 2-14. Structural hierarchy of tendon: collagen molecules aggregate to form fibrils; 
fibrils group together to form fibers; fibers bundle together to form fascicles; fascicles group 
together to form tertiary fiber bundles which act as the primary tendon unit. Connective tissue 
called endotenon surrounds the bundles and fascicles. Although the diagram does not show 
fibril subunits, collagen fibrils appear to be self-assembled from intermediates that may be 
integrated within the fibril (modified from Silver et al., 2003).  
 
Tendon consists predominantly of collagen type I, and to a lesser degree other 
fibrillar (type III and V) and non-fibrillar collagens (type XII and XIV), proteoglycans 
and glycoproteins. Both collagen V and III form heterotypic alloys with collagen I and 
have the retained/slowly processed N-terminal domains typical of the regulatory fibril-
forming collagens. During tendon development, there are at least three distinct steps 
in fibrillogenesis: molecular assembly of collagens, linear growth step; and lateral 
growth step (Fig. 2-15). Tissue-specific fibrillogenesis would involve the independent 
regulation of each step. During tendon development there are changing expression 
patterns for FACIT collagens and the leucine-rich proteoglycans (Ezura et al., 2000; 
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Young et al., 2000; Zhang et al., 2003). For example, the expression level of collagen 
XIV, biglycan and lumican changed drastic from early development to maturation of 
tendon. In the absence of any of the four proteoglycans the regulation of fibril growth 
in tendon is abnormal (Danielson et al., 1997; Jepsen et al., 2002; Young et al., 
2000). 
 
Figure 2-15. Tendon fibrillogenesis. (A) Molecular assembly 
of type I and III and/or V collagens generates the fibril 
intermediate. It can be hypothesized that heterotypic 
interactions are a mechanism regulating this assembly step. 
(B) In the linear growth step, the intermediates in (A) grow by 
end-to-end growth to generate longer fibrils. Alterations in 
molecular interactions, at the α and β ends of the 
intermediate, initiate and control this growth. (C) In the lateral 
growth step, there is a lateral association and growth of the 
developing fibrils. Alterations in interactions mediated by 
fibril-associated molecules (ovals) along the main fibril shaft 
regulate this step (Zhang etl al., 2005). 
 
 
 
 
In tendons, collagen fibrils are dense, well organized and aligned in parallel along the 
main axis of tension (Kastelic et al., 1978). In contrast to the cornea, the collagen 
fibrils in tendon have significant increases in diameter during development and 
growth, which supplying stability and tensility of tendon. Particularly, the parallelism 
of tendon fibril formation is determined by the late secretory pathway and interaction 
of adjacent membrane protrusions to form extracellular channels called fibripositors. 
There are two models described about fibripositor formation during collagen 
fibrillogenesis in tendon according to the Birk model and Kadler model (Birk and 
Trelstad, 1986; Canty et al., 2004; Richardson et al., 2007). Moreover, it has been 
shown that actin filaments are required for fibripositor-mediated collagen fibril 
alignment in tendon (Canty et al., 2006) 
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3. AIM OF THE PRESENT STUDY 
 
This present study has the aim to understand the relationship between cross-link 
formation and collagen fibril organization in chicken embryonic cornea and tendon. 
The fibrillar organizations in cornea and tendon are vastly different although both 
tissues contain collagens I and V as their major collagenous components. Collagens 
have to be cross-linked to exhibit the normal physical properties, in which all the fibril-
forming collagens (types I, II, III, V, and XI) and the fibril-associated type IX collagen 
rely on this mechanism of cross-linking to provide tissue structural integrity and 
material function (Eyre et al., 2005). Therefore, it is interesting to investigate the 
collagen fibril organization in embryonic chicken at the tissue level, employing a 3D 
cell culture system with and without cross-link formation using cross-link-specific 
enzyme inhibitors. The objectives of this study were the following: 
 
(i)     To prepare 3D cell cultures of fibroblasts isolated from chicken embryonic 
cornea or tendon with or without cross-link formation.  
 
(ii)     To obtain collagenous matrices from 3D culture. 
 
(iii)    To check the suprastructural organization and macromolecular components of 
matrices with or without cross-link formation by transmission- and immuno-gold 
electron microscopy. 
 
(iv)  To determine the existence of cross-link as well as the relevant enzyme activity 
during ECM formation. 
 
(v)   To supplement the data from cell-culture-system with in-vitro fibrillogenesis 
experiments. 
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4 MATERIALS AND METHODS 
4.1 CHEMICALS AND ANTIBODIES  
4.1.1 Chemicals 
Name Supplier 
L-proline, [14C(U)]- 0.1 mCi/ml Hartmann Analytic, Germany 
2-propanol Roth, Karlsruhe, Germany 
Acetic acid Merck, Darmstadt, Germany 
Alexa Fluor® 555 cadaverine, disodium salt Invitrogen 
Boc-DON-Gln-IIe-Val-OMe 
Tissue transglutaminase inhibitor 
ZEDIRA GmbH 
Bovine serum albumin (BSA) Sigma-Aldrich, Steinheim 
Calcium chloride Merck, Darmstadt, Germany 
CF626 radioactive molecular marker Amersham Biosciences, UK  
Coagulation factor XIII from human plasma 
Approximates 1,000 µg / 5,000 µg factor XIII 
ZEDIRA Gmbh 
Collagenase B 
0.191 U/mg lyo. from Clostridium histolyticum 
Roche Diagnostics GmbH, Germany 
Dimethylsulfoxide (DMSO) Merck, Darmstadt, Germany 
2,5-diphenyloxazol Sigma-Aldrich, Steinheim 
Dry skim milk Fluka Chemie GmbH, Switzerland 
Ethanol AppliChem, Darmstadt, Germany 
Ethylendiamine tetra acetic acid (EDTA) Fluka Chemie GmbH, Switzerland 
Fluoromount G Southern Biotech, USA 
Formaldehyde 8% Polysciences, Inc., Eppelheim, Germany 
Glutaradehyde 8% Polysciences, Inc., Eppelheim, Germany 
Glycerol Roth, Karlsruhe, Switzerland 
L-Cysteine Hydrochloride Monohydrate Sigma-Aldrich, Steinheim, Germany 
L-Lysine, [4,5-3H(N)]- 1.0 mCi/ml; 3.3 µg/ml Hartmann Analytic, Germany 
L(+)-Ascorbic acid Merck, Darmstadt, Germany 
LR-White Agar Scientific, Stansted, UK 
Lumasafe Plus LUMAC. LSC, Holland 
MEM Eagle w/Earle’s, L-Glutamine w/o 
Leucine, Lysine, Methionine (powder) 
USBiological 
Methanol AppliChem, Darmstadt, Germany 
Paraffin Roth, Karlsruhe, Germany 
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Penicillin / Streptomycin PAA Laboratories GmbH, Pasching 
Pepsin Serva, Heidelberg, Germany 
Polyacrylamide Roth, Karlsruhe, Germany 
Recombinant human tissue transglutaminase 
(His6-rhTG2), 250 µg / 1 mg dry substance 
ZEDIRA GmbH 
Roti-Histol Roth, Karlsruhe, Germany 
Sodium pyruvate Fluka Chemie GmbH, Switzerland 
Sodium chloride AppliChem, Darmstadt, Germany 
Sodium di-hydrogen phosphate dihydrate Merck, Darmstadt, Germany 
Sodium dodecyl sulphate (SDS) Serva, Heidelberg, Germany 
ß-Aminopropionitrile fumarate salt (BAPN) Sigma-Aldrich, Steinheim, Germany 
Thrombin, human plasma Calbiochem®, Germany 
Trichloro acetic acid (TCA) Merck, Darmstadt, Germany 
Tris (hydroxymethyl)-aminomethan MP Biomedicals, Eschwege, Germany 
Trypsin-EDTA PAA Laboratories GmbH, Pasching 
Uranyl acetate Merck, Darmstadt, Germany 
 
4.1.2 Antibodies 
4.1.2.1 Primary antibodies 
Protein 
Antibody 
Name/clone 
Immunofluorescence (IF), 
Western blot (WB),   
Immuno gold (EM), 
Immunohistochemistry 
(ICH) 
Donor 
aminal 
Reference/ 
Source 
Collagen I AB752P IF, WB, EM, ICH rb Chemicon 
Collagen VI 39 IF, WB, EM ms Developmental 
Studies 
Hybridoma Bank 
Fibronectin B3/D6 IF, WB, EM ms Developmental 
Studies 
Hybridoma Bank 
Cytokeratin AE1/AE3 IF, ICH ms Acris Antibodies 
Elastin MAB2503 IF, WB ms Chemicon 
Decorin CB-1-c IF, WB, EM ms Developmental 
Studies 
Hybridoma Bank 
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4.1.2.2 Secondary antibodies 
Name Reference/Source 
Alexa Fluor® 488, goat anti-rabbit IgG (H+L) Invitrogen 
CyTM3-conjugated AffiniPure Goat Anti-Mouse IgG (H+L) Jackson ImmunoResearch 
Colloidal Gold-AffiniPure Goat Anti-Rabbit IgG (H+L) (18nm) Jackson ImmunoResearch 
Colloidal Gold-AffiniPure Goat Anti-Mouse  IgG (H+L) (12nm) Jackson ImmunoResearch 
 
4.2 CELL CULTURE 
4.2.1 3D cell culture 
Fibroblasts were isolated from 17-day-old chicken cornea or tendon. After the 
dissection of the central parts of cornea, the tissues were washed 3 times in Krebs 
buffer (118 mM NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 4.2 mM 
NaHCO3, 2 mM CaCl2, 10 mM glucose, 200 µM sodium pyruvate and 10 mM Hepes, 
pH 7.4). Subsequently, epithelial cells were removed from the tissue fragments by 
digestion in 0.25% (w/v) trypsin / 2mM EDTA solution in Krebs buffer for 15 min in 
Petri dishes. After 3 futher washing steps, the tissues were minced and matrix-free 
fibroblasts were obtained by incubation with 1mg/ml collagenase B (0.191 U/mg lyo. 
from Clostridium histolyticum, lyophilized, Roche, Germany) in DMEM supplemented 
with 10% FCS and 1% penicillin-streptomycin, added to avoid bacterial 
contamination. The dishes were kept overnight in a humidified-atmosphere incubator 
at 37°C and with 5% CO2. The cells then required 3 washing steps with DMEM and 
centrifugation (1000 rpm, 5 min, S4180, Beckman), and were resuspended in DMEM 
(10% FCS), counted in a Neubauer chamber, and distributed in a 24-well-plate 
(Nunc, Roskilde, Denmark) with a culture surface about 1.9 cm2 pro well. The cell 
density was about 2×105 pro well. Cells were cultured overnight and then 
supplemented with 0.14 mM L(+)-ascorbic acid, 1 mM sodium pyruvate and 1 mM L-
cysteine. The crosslink inhibitors were added to give final concentrations of 0.2 mM 
ßAPN and / or 5 µM TG-inhibitor (Boc-DON-Gln-Ile-Val-OMe, ZEDIRA GmbH). After 
14 days of cultivation the fibroblasts formed multilayer cell matrices which were 
removed from the wells with a spatula.   
 
4.2.2 Immunofluorescence of cell culture in µ-slides (ibidi) 
The ibidi µ-Slide VI0.4 is a 6-channel µ-slide, which is suitable for small-scale cell 
cultivation (30 µl channel volume) and multiple immunofluorescence staining (work 
principle see Fig. 4-1). Fibroblasts were taken up in 1 ml DMEM medium containing 
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10% FCS, 1% penicillin-streptomycin and counted using a Neubauer chamber. 30 µl 
cells were seeded into each channel at a density of 3×105 cells/ml and the slides 
were incubated at 37°C and with 5% CO2 for 2-3h. For each channel 90 µl cell-free 
medium (supplemented with 0.14 mM L(+)-ascorbic acid, 1 mM sodium pyruvate, 1 
mM L-cysteine, 0.2 mM ßAPN or / and 5 µM TG-inhibitor) was filled, for a further 
cultivation for 2-7 days until cells grew dense in each channel. 
 
                            
Figure 4-1. Work principle of ibidi-slide for immunofluorescence staining. 
 
4.3 PROTEIN CHEMISTRY 
4.3.1 Collagen purification 
An overview of the procedures used for collagen purification is shown in Figure 4-2. 
17-day-old embryonic chicken corneas were washed 3 times in PBS (20 mM sodium 
phosphate buffer, pH 7.4, containing 0.15 M NaCl). All of the following steps were 
performed at 4°C. Collagens were extracted in 15 volumes of 0.5 M acetic acid by 
stirring overnight. Supernatants (S1) were recovered by centrifugation (10,000 rpm, 
30 min, JLA10.500, Beckman). This step was repeated and the supernatants (S2) 
were combined. The whole supernatants (S1+S2) were again centrifugated (14,000 
rpm, 30 min, JA10.50, Beckman) and pellets were discarded. Subsequently, 25% 
[w/v] solid NaCl was dissolved in 0.5 M acetic acid (V = 25%(S1+S2)) and added into 
the crude mixture of collagens very slowly by stirring overnight. Total collagens (A) 
were obtained by centrifugation (10,000 rpm, 1.5 h, JLA10.500, Beckman) and 
dissolved in 0.05 M Tris-HCl, pH 7.4 containing 2 M urea, 0.2 M NaCl. Here, total 
collagens (A) were mixture of collagens and proteoglycans. 
 
For chromatographic separation, the crude collagen pellets were dissolved in 0.05 M 
Tris-HCl, pH 7.4, containing 2 M urea, 0.2 M NaCl. After dialysis against the same 
buffer the crude mixture was passed over a DEAE-cellulose column (3.5×21 cm, 200 
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ml, DE52; Whatman Ltd.), equilibrated with the same buffer. Total collagens (B) were 
recovered from the breakthrough fraction while other proteins containing 
proteoglycans (“rest”) were bound to the column. The column was eluted with buffer 
containing 1 M NaCl in order to discard the “rest” proteins from the column. The 
product was a mixture of total collagens (B) without proteoglycans. 
 
The total collagens (A) and (B) were dialyzed extensively against 100 mM Tris-HCl, 
pH 7.4, containing 1 M NaCl, and were precipitated by adding solid NaCl to a final 
concentration of 4.5 M. After centrifugation, pelleted precipitates were redissolved in 
storage buffer (0.1 M Tris-HCl, pH 7.4, containing 0.4 M NaCl) at appropriate 
concentrations and were clarified by centrifugation. The purified and concentrated 
collagen mixtures with or without proteoglycans were used for in-vitro fibrillogenesis. 
 
               
 
Figure 4-2. Flowchart representation of the protocol for purification of corneal collagen 
mixtures with or without proteoglycans from embryonic chicken cornea. 
 
4.3.2 SDS-PAGE 
Samples were pooled and prepared for electrophoresis by precipitation with three 
volumes of cold ethanol. The precipitates were resuspended in SDS sample buffer 
(10 mM Tris-HCl, pH 6.8, containing 10% [v/v] glycerol, 0.03% bromphenol blue, 2% 
sodium dodecyl sulphate, 0.5 M urea) and boiled at 95°C for 5 min, then loaded on 
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4.5-8% polyacrylamide gradient gels under non-reducing conditions. After 
electrophoretic separation, the gels were dehydrated for further analysis by 
fluorography (see 4.7). 
 
4.4 IN-VITRO FIBRILLOGENESIS   
An overview of the procedures used for in-vitro fibrillogenesis is shown in Figure 4-3. 
The crude mixture of corneal collagens from embryonic chicken (see 4.3.1) in storage 
buffer was degassed under vacuum. In-vitro fibrillogenesis was carried out in a 
microcuvette (Multicell, light path, 1 cm, Beckman, Palo Alto, CA) and was initiated 
by diluting the collagen mixtures with an equal volume of distilled water. Where 
appropriate, tissue transglutaminase, CaCl2, factor XIII, and thrombin were added to 
the mixtures directly after dilution. The kinetics of fibrillogenesis was monitored by 
measurement of the development of turbidity at 313 nm. The reconstitution products 
were examined by (immuno-) electron microscopy. 
 
 
Figure 4-3. Procedure of in-vitro fibrillogenesis with purified collagens. 
 
4.5 HISTOCHEMISTRY 
4.5.1 Preparation of paraffin-embedded matrices 
Matrices deposited during 14-days of 3D-culture by corneal fibroblasts were gently 
detached from cell culture wells and washed 3 times in PBS, and were fixed in 4% 
paraformaldehyde overnight at 4°C. The fixed cell cultures were washed in PBS 
again and folded carefully in OBI specimen paper. The packed cells were put in an 
embedding-cassette and washed in floating distilled water for at least 1h; then 
dehydrated in the following solvents under continuous stirring:  
1) 2h 50% ethanol at 4°C 
2) 2h 70% ethanol at 4°C 
3) overnight 96% ethanol (I) at 4°C 
4) 4h 96% ethanol (II) at 4°C 
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5) 2h 2-propanol (I) at 4°C 
6) 2h 2-propanol (II) at 4°C 
 
Afterwards cassettes were sequentially put into inter-medium containing 50% 2-
propanol and 50% paraffin mild for 24h at 60°C, in paraffin mild (I) for 12h at 60°C, in 
paraffin mild (II) overnight at 60°C, in paraffin hard for 12h at 60°C. Finally, the 
treated cells were cast in paraplast. Paraffin blocks were cut with a microtome 
(MICROM Cool-Cut HM 355), the sections were picked up on glass slides, and dried 
overnight at room temperature. 
 
4.5.2 Immunofluorescence staining of paraffin sections 
Sections were incubated in a drying oven for at least 30 min at 60°C. 
Deparaffinization and rehydration were performed with following procedures: 
1) 2 times washes of Roti-Histol for 5 min 
2) 50%, 70%, 90%, 100% ethanol for 5 min each 
3) sections rinsed in distilled water for 5 min 
 
All following steps were carried out in a wet and light-tight chamber to prevent drying 
and fluorochrome fading. Sections were washed in PBS for 5 min and encircled with 
DakoPen. Isolated sections were washed again in PBS for 3-4 times and blocked 
with 2% BSA (in PBS) for 45 min at room temperature. Subsequently they were 
incubated with primary antibody solution containing 1% BSA in PBS at 4°C overnight. 
Sections were rinsed 3 times in PBS for 5 min and incubated with secondary 
antibody solution containing 1% BSA and DAPI (1:10,000 in PBS) for 1h at 37°. 
Finally, sections were rinsed in PBS for 3 times again and covered with Fluoromount 
G (Southern Biotech). Slides were examined using a Zeiss Axio Imager microscopy 
equipped with fluorescent optics and documented using a Hamamatsu ORCA ER 
camera. Images were analyzed using Volocity 4.2 software (Improvision). 
 
4.5.3 Immunofluorescence staining of cells 
Immunofluorescence staining of cells was carried out directly in µ-slides (ibidi), which 
had a confluent cell density after 3-7 days growth. Cells were washed 3 times in PBS 
and then fixed with cold methanol for 10 min at -20°C. After another 3 washing steps, 
cells were permeabilized with 0.1% Triton X-100 in PBS for 10 min at room 
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temperature. Cells were washed in PBS, again, and blocked with 2% BSA in PBS for 
45 min at room temperature. Afterwards cells were incubated with primary antibody 
solution containing 1% BSA in PBS overnight at 4°C. Bound primary antibodies were 
visualized using Cy3- or Alexa 488 conjugated secondary antibodies (Jackson 
Laboratories & Molecular Probes) containing 1% BSA and DAPI (1:10,000 in PBS) by 
1h incubation at room temperature. Cells were washed again and covered with 
fluoromount G. Slides were examined using a Zeiss Axio Imager microscopy 
equipped with fluorescent optics and documented using a Hamamatsu ORCA ER 
camera and with a Zeiss confocal laser scanning system LSM 510 meta. Images 
were analyzed using Volocity 4.2 software (Improvision). 
 
4.6 IMMUNO-GOLD ELECTRON MICROSCOPY 
4.6.1 Preparation of ultrathin sections 
14-days-cultured cornea or tendon fibroblasts were gently detached from cell culture 
wells and then fixed in fix buffer overnight (0.1M cacodylate buffer in distilled water, 
pH 7.4, containing 2% [v/v] formaldehyde and 2.5% [v/v] glutaraldehyde). After 
washing 3 times in PBS over 1h, specimens were dehydrated with an ethanol series 
from 30% to 70%. Subsequently, the specimens were taken into LR White (Agar 
Scientific, Stansted, UK) / 70% ethanol (2:1) overnight at 4°C before embedding in 
pure LR-White. Pure LR-White was changed for 5 times within 2–5 days until the 
samples were ready for embedding. Samples were then embedded in LR-White 
using a plastic template (TED RELLA INC bedding CA) and were exposed to UV-light 
for 24-48h for complete polymerization. Blocks were cut on an Ultramicrotome 
(Reichert-Jung, Austria) using a diamond knife (ultra 35° MT7239, DiATOME, histo 
HI7900 or ultra 35° MT7239). Ultrathin sections were picked up on nickel grids (200 
square mesh), covered with formvar and coated with carbon, and dried at room 
temperature. 
 
4.6.2 Immuno-gold electron microscopy 
All following steps were carried out at room temperature. Grids with ultrathin sections 
were floated on drops of 100 mM glycerol in PBS for 30 seconds in order to reduce 
electrostatic charges. Alternatively, 20 µl reconstituted products from in-vitro collagen 
fibrillogenesis was spotted onto sheets of parafilm. Nickel grids were floated on the 
drops for 10 min to allow adsorption of fibril fragments. Thereafter, grids were dried 
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on filter paper, then washed once with PBS, and treated for 30 min with 2% [w/v] 
dried skim milk in PBS (2% blocking solution) which was centrifuged twice at 14,000 
rpm for 10 min. Primary antibodies were diluted to appropriate concentrations with 
0.2% blocking solution and the grids were allowed to react for 2h. After washing 4 
times with PBS, grids were incubated for 2h with 0.2% blocking solution containing 
secondary antibodies (12 or 18 nm colloidal gold particles coated with goat anti-rabbit 
or anti-mouse immunoglobulins, diluted 1:30). The grids were then washed 4 times 
with distilled water and negatively stained with 2% [w/v] uranyl acetate for 7-10 min. 
Finally, grids were washed again with distilled water and dried in a grid box. For 
double-labeling experiments, a mixture of gold particles of two different sizes was 
used. In negative controls, grids were treated with blocking buffer instead of primary 
antibody solutions. Electron micrographs were taken at 80 kV using a transmission 
electron microscope (Philips EM410). The imaging plates were scanned with a digital 
film scanner (Micron imaging plate scanner, Ditabis, Pforzheim, 6000 × 5000 pixel). 
 
4.7 FLUOROGRAPHY OF SDS-PAGE 
Collagens newly synthesized by corneal fibroblasts and separated by SDS-PAGE 
were visualized by fluorography. Cells were cultured for 24h or 6 days in the 
presence of 1 µCi/ml 14C-proline (Hartmann analytic, Braunschweig, Germany), L(+)-
Ascorbic acid, sodium pyruvate, L-cysteine, and crosslink inhibitors (TG-inhibitor / 
ßAPN: -/-, +/-, -/+ or +/+ respectively). Media were removed and cell layers were 
harvested in 1.5 ml HAc, containing 1 mg/ml pepsin. Proteins were digested under 
stirring by rotation for 2h at room temperature. Salt-precipitation was performed by 
adding 1.2 M NaCl and stirring overnight at 4°C. After centrifugation at 14,000 rpm 
for 30 min, cell pellets were resuspended in 100 mM Tris-HCl, 150 mM NaCl, pH 8.6, 
and were precipitated again by adding three volumes of cold ethanol for at least 2h. 
Cells were centrifuged again and resuspended in 100 µl of distilled water. Ethanol 
precipitation was repeated and pellets were dried. Cell lysates digested with pepsin 
were resuspended in 50 µl of 5-fold concentrated sample buffer (details described in 
4.3.2) without reducing agents and heated to 95°C for 5 min. 2 µl aliquots of the 
labeled proteins or 2 µl molecular marker solution (CF626, Amersham Biosciences / 
GE Healthcare, Chalfont St Giles, UK) were diluted in 2 ml “Lumasafe Plus” (Lumac 
LSC, Groningen, Netherlands), and were counted in a “scintillation counter” 
(Beckman, Fullerton, USA). Samples were loaded with same volume (luminescence 
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“counts” varies from approximately 8000 to 25000) on 4.5-8% polyacrylamide 
gradient gels. After electrophoretic separation, the gels were dehydrated 3 times in 
DMSO and incubated in 20% (w/v) diphenyloxazol in DMSO for at least 3h. After 45 
min of rehydration in distilled water, gels were dried on a gel dryer (Bio-Rad, 
Hercules, USA), exposed on a X-ray film (Thermo Fisher Scientific Inc, USA) for 7-14 
days at -80°C, resulting in visualization of band patterns of radioactively labeled 
proteins. The films were developed and were scanned with a HP scanjet 7400C. 
Band intensities were analyzed with ImageJ 1.44 software. 
 
4.8 TOTAL PROTEIN ASSAY  
The total protein assay is based on the detection of hydroxyproline which is a 
collagen-specific amino acid in mammals. The amount of hydroxyproline in 
hydrolysates of conditioned cell extracts can be used as a direct measure of total 
collagen in ECM. The measurement is started by complete hydrolysis of corneal 
fibroblast cell layers in 6M HCl at 110°C for 20h. In the hydrolysate, hydroxyproline 
residues were quantified using the QuickZyme total collagen assay kit (QuickZyme 
biosciences, work principle sees Fig. 4-4). Collagen I from chicken embryonic tendon 
or bovine serum albumin (BSA) was used as standards or as negative controls, 
respectively. 
 
                        
Figure 4-4.  Work principle of total protein assay  
 
4.9 MEASUREMENT OF LOX ACTIVITY: 3H-RELEASE  
4.9.1 Preparation of substrate 
18 aortas from 17-day-old embryonic chickens were incubated in a 50-ml Erlenmeyer 
flask with 10 ml Eagle´s MEM with Earle’s salts lacking free L-lysine (USBiological) 
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but containing 200 µCi L-[4,5-3H]lysine (Hartmann Analytic) and 20 µg/ml ßAPN. 
Flasks were incubated at 37°C and 5% CO2 for 24 h. After incubation, the aortas 
were rinsed with distilled water and dried in a SpeedVac® concentrator (Savant). Dry 
aortas were homogenized in phosphate-buffered saline (0.15 M NaCl, 0.1 M 
Na2HPO4, pH 7.8) and centrifuged (11,000 g, 30 min, S4180, Beckman). 
Supernatants were discarded; the pellets were rehomogenized in saline and 
recoverd twice more by centrifugation. Finally, the substrates were suspended in 
0.01M HCl, collected by centrifugation and dried again in SpeedVac® concentrator. In 
general, substrates equivalent to the pellet from two aortas containing approximately 
500,000 cpm3H were used per incubation. 
 
4.9.2 Assay of lysyl oxidase 
Cell layers from corneal fibroblasts cultured for 14 days were homogenized in PBS 
with Polytron® (KINEMATICA AG), then centrifuged at 4800 rpm for 3 min (S4180, 
Beckman). The supernatants were applied for activity assay. The enzymic reaction 
was carried out for 4h at 37°C in a volume of 1ml containing 300,000-500,000 cpm of 
3H-labeled substrate. Controls were done with radioactive substrates and buffer. 50 
µl of 2% BSA was added to each assay tube and precipitated by TCA together with 
the substrate proteins. 2 µl supernatants containing tritiated water formed by 
enzyme-catalyzed reaction were diluted in 2 ml “Lumasafe Plus” (Lumac LSC, 
Groningen, Netherlands), and were counted by liquid scintillation as described 
above. 
 
4.10 DEMONSTRATION OF TG ACTIVITY VIA FLUORESCENCE-LABELED 
CADAVERINE 
Corneal fibroblasts were cultured in µ-slides (ibidi) as described in 4.2.2. At day 2, 
0.1 mM Alexa Fluor® 555 (Invitrogen)-conjugated cadaverine was added to cell 
culture and slide was kept in incubator at 37°C and with 5% CO2 for further 12h in the 
presence or absence of TG-inhibitor (Boc-DON-Gln-IIe-Val-OMe, ZEDIRA). 
Afterwards, cells were washed 3 times in PBS and covered with fluoromount G. 
Slides were examined using a Zeiss AxioImager microscopy equipped with 
fluorescent optics and documented using a Hamamatsu ORCA ER camera and with 
a Zeiss confocal laser scanning system LSM 510 meta. Images were analyzed using 
Volocity 4.2 software (Improvision). 
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5 RESULTS 
 
5.1 The tissue-specific matrix organization in chicken cornea is crucially 
influenced by cross-link formation.  
In early studies, Ruberti and co-workers have shown that human corneal fibroblasts 
produced lamellae of fibrils with resemblance to those in the developing mammalian 
cornea (Guo et al., 2007). In his work, primary fibroblasts were allowed to emigrate 
from tissue fragments and were subsequently subjected to cell culture. In this thesis 
project, matrix-free keratocytes were isolated from 17-day-old chicken embryonic 
cornea by digestion with bacterial collagenase. The collagenous matrices with and 
without cross-links were obtained from keratocytes cultivated in 3D-cultures for 14 
days. The arrangement of the collagen fibrils and the fibril diameter distribution 
depended on cross-link formation and were analyzed on ultrathin sections of 3D 
matrices by electron microscopy. 
 
Electron micrographs revealed orthogonal arrays of fibrils deposited by the 
keratocytes under conditions allowing the formation of LOX- and TG-derived cross-
links, i.e. in the absence of enzyme inhibitors (Fig.5-1 A). Orthogonal stacks were 
formed of arrays of uniformly thin collagen fibrils. Equidistantly spaced in parallel to 
yield so-called “lamellae” construct. Although the arrangement of lamellae is compact, 
at least nine lamellae (red arrows) were found with a change in collagen orientation 
(cross section – longitudinal section). Panel B shows a high magnification section of 
the micrograph shown in panel A. The authentic corneal stroma is composed of 
collagen fibrils of a uniform diameter, embedded in a highly hydrated matrix made up 
mostly of proteoglycans (Quantock et al., 2001; Meek et al., 2003). The authentic 
corneal fibrils are remarkable in the uniformity of their diameters and the regularity of 
their spacing. We found that the lamellae composed of homogeneous fibrils in our 
cell cultures had an organization highly similar to that of authentic mature corneal 
fibrils. However, formation of these lamellae was abrogated in the presence of the 
LOX inhibitor ßAPN. The fibrils were disorganized and thin, network-like structures 
between normal collagen I containing fibrils (C, D) were apparent. Such thin fibrils 
were not labeled with antibodies to collagen I or collagen VI. By contrast, in the 
presence of a TG inhibitor, the collagen fibrils were thicker, but the organization into 
lamellae was less affected (E, F). At high magnification (inset in panel E), thicker 
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fibrils were revealed with clear banding pattern (D-period) which was not seen under 
other conditions of cross-link formation. The diameters of fibrils formed in the 
presence of TG-inhibitor were also very homogeneous. Interestingly, the presence of 
both cross-link inhibitors leads to striking effects on matrix formation: the organization 
of fibrils in lamellae is lost (G-J), and the fibrils themselves were abnormal in that they 
had a bimodal and broad diameter distribution (G, H). Fibrils were very thin (diameter 
15 nm - 30 nm) in one region and much thicker, but disrupted in structure in a 
neighboring region (diameter 45 nm – 150 nm). Such “abnormal” fibrils could be 
labeled with collagen I antibody gold conjugates (small gold particles indicated by red 
arrows in micrograph H), proving their collagenous nature. In some cases there are 
very few fibrils formed close to keratocytes (J) and exhibited weak or diffuse banding 
patterns (I).  
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Figure  5-1. Suprastructures of matrices deposited by keratocytes. Control condition allowing 
for LOX- and TG-derived cross-link formation (A, B); in the presence of LOX-inhibitor ßAPN 
(C, D); or in the presence of a TG-inhibitor (Boc-DON-Gln-IIe-Val-OMe) (E, F); or with both 
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inhibitors (G-J). Small gold particles (red arrows) indicate the localization of collagen I (H). 
Keratocyte cells were marked with “K”. Bars: 200 nm. 
 
5.2 Addition of cross-link inhibitors changed fibril diameter distribution in 
keratocytes. 
The analysis of fibril diameter distributions unraveled further morphological details of 
collagen fibrils formed in keratocytes. All diameters of collagen fibrils were measured 
on the basis of ultrathin sections, either of 17-day-old embryonic chicken cornea (Fig. 
5-2 A) or of 3D matrices from 14-days chicken cultures of keratocytes by electron 
microscopy (B, C, D, E). 
 
Fibrils formed by keratocytes under control conditions were only slightly thicker 
(diameter distribution B: 45.60 ± 12.16 nm, n = 758) than those in corneal tissue (A: 
35.48 ±10.81 nm, n = 714). In the presence of ßAPN, the fibrils had a broader 
distribution and larger diameters (C: 59.01 ± 25.36 nm, n = 918). Interestingly, fibrils 
formed in the presence of TG-inhibitor were obviously thicker. There was a large shift 
of diameter distributions towards higher values (D: 110.31 ± 15.75 nm, n = 593). This 
result is consistent with the electron microscopic observation that fibrils were 
generally thicker with clearly visible banding pattern. Under the culture conditions 
with both cross-link inhibitors, diameter distributions were bimodal (E: 59.97 ± 26.88 
nm, n = 1198): there was a population with small diameter (peak at about 20-25 nm), 
while the other at 50-55 nm of diameter. When the formation of both cross-links was 
prevented, a loss of matrix organization and heterogeneous fibril distribution was 
observed which clearly differed from the fibril populations when only one type of 
cross-link was inhibited. 
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Figure 5-2. Analysis of fibril diameter distribution: The diameter of collagen fibrils were 
measured on ultrathin sections of authentic tissue (A) or of 3D matrices from chick cultures of 
keratocytes from cornea by electron microscopy (B-E). 
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5.3 Cross-links derive from both lysyl oxidase and transglutaminase in chicken 
keratocytes.  
Collagen-fluorography of 14C-proline labeled keratocytes was analyzed with respect 
to cross-linked components under different inhibitor conditions and at different time 
points of culture. The 3D-cultured keratocytes were metabolically labeled with 14C-
proline for 6 days or 24 hours. The harvested cell matrices were pepsin-solubilized, 
collagens were salt-precipitated, and SDS-PAGE was run under non-reducing 
conditions. The result from cell layers labeled for 6 days is shown in figure 5-3 A. 
Four lanes indicated four different conditions of cross-link formation, specified at the 
bottom of each lane. The cross-link products were classified into five groups:  
i) dimer of α1- and/or α2-chains (β-components); 
ii) trimer of α1- and/or α2-chains (γ-components); 
iii) tetramer of α1- and/or α2-chains; 
iv) further oligomer; 
v) potential polymers containing non-collagenous proteins substituted by GAG 
 chains.  
 
Some products resulted from exclusive LOX-dependent cross-linking. These were 
the fastest migrating band of the β-components, all γ-components, as well as further 
oligomers which appeared only when LOX activity was intact (green arrows). These 
cross-links could be essential for the generation of lamellar structures, but less 
necessary for the regulation of the fibril diameter. In addition, there are products of 
both LOX- and TG-dependent cross-linking. The tetramers are dependent on both 
cross-links. Each of the enzymes produced about half of the tetramers (blue arrows), 
since inhibition of both enzymes leads to absence of tetramers (red arrows). The 
further oligomers, whose formation is LOX-dependent, display similar patterns as 
trimers and dimers. The polymers presented dependence of cross-link products on 
the enzyme inhibitors similar to that of tetramers with each of the enzymes 
contributing about half of them. Solely TG-dependent cross-link products were not 
formed in these experiments.  
 
Furthermore, in order to investigate the onset of cross-link formation, 24-hour 
metabolic labeling was done and the result is shown in figure 5-3 B. At the beginning 
of fibril formation and organization, LOX-dependent cross-links have partly formed 
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(green arrows near γ-components), but the fastest migrating band of β-components 
has not yet appeared (green arrows near ß-components). The LOX- and TG-
dependent cross-link products of tetramers represent no difference in form, which 
implies delayed functions of TG-derived cross-link formation. The further oligomers 
and polymers were not yet formed within 24 hours. 
 
To summarize all observations of collagen-fluorography, cross-links do derive from 
both LOX and TG in chicken keratocytes. LOX-derived cross-link formation is initiated 
at early stages of fibril formation and had a sustained influence at later stages of fibril 
organization, while TG-derived cross-links formed later. These observations suggest 
that LOX-derived cross-links are formed at the beginning of fibril organization and 
eventually led to the formation of lamellae. TG contributes to the adjustment of fibril 
diameters at later stages of fibril organization. 
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Figure 5-3. Cross-link analysis of cultured keratocytes labeled with 14C-proline for 6 days (A) 
or 24 hours (B). The cell matrices of 3D-cultures were pepsin-solubilized, collagens were 
salt-precipitated and SDS-PAGE was run under non-reducing conditions. Gel exposures on a 
X-ray film finally. Green arrows: LOX-dependent cross-links; blue arrows: both enzyme-
dependent cross-links; red arrow: absence of cross-link product. 
 
5.4 Keratocytes produced less collagen V in the presence of LOX inhibitors, 
and more collagen V in the presence of TG inhibitors 
Except for cross-link analysis, the relative amounts as well as proportion of collagen 
α-chains were studied. This densitometric analysis is based on the same gels of 
collagen-fluorography, which are described in section 5.3. The α-chains were derived 
from cultured keratocytes metabolically labeled with 14C-proline for 6 days or 24 
hours under different cross-linking conditions. 
 
Three α-bands are visualized by fluorography: α1 and α2 bands of type I collagen, 
and one band of type V collagen (Fig. 5-4, left diagrams in A, B). In column diagrams, 
blue columns represent the ratio of α2 and α1 bands of collagen I. Red and green 
columns represent the intensity of the collagen V band compared with α1 or α2 band 
of collagen I, respectively. Keratocytes produced less collagen V in the presence of 
LOX-inhibitors after 6-day cultivation (A: plot 1 vs. 3). In cultures with TG-inhibitor, 
more collagen V was produced (A: plot 1 vs. 2). Inhibition of both enzymes led to a 
slight reduction of collagen V (A: plot 1 vs. 4). This change of collagen I/V proportions 
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could affect the formation and organization of corneal fibrils because the corneal 
fibrils are heterotypic I/V fibrils. By contrast, the proportions of α1 and α2 bands of 
collagen I were not clearly affected by cross-link formation (A: blue columns), which 
means that the chain composition of collagen I didn´t depend on cross-links 
formation as expected. In comparison with cultures labeled for 6-days, the relative 
amounts of collagen α-bands extracted after 24h of labeling are comparable whether 
or not LOX- or/and TG-derived cross-link formation was allowed (B). After 24h of 
cultivation only a small amount of collagen V was obtained. However, under control 
conditions, a maximum of collagen V was produced (B: plot 1). A minimum of 
collagen V appeared under the condition of LOX inhibition (B: plot 3).  
 
 
 
 
Figure 5-4. Densitometric analysis of collagen α-bands in cultured keratocytes labeled 
with14C-proline for 6 days (A) or 24 hours (B). The cell matrices of 3D-cultures were pepsin-
solubilized, collagens were salt-precipitated and SDS-PAGE was run under non-reducing 
conditions. 
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5.5 Keratocytes predominate in preparations of corneal cells. 
5.5.1 Cell preparations virtually exclusively contain corneal fibroblasts at early 
stages of fibril organization. 
Since initial preparations of primary corneal cells not only contain keratocytes, but 
also epithelial cells, we were interested in the question of which cell type survived 
after prolonged culture. The cell types in our cultures were identified with a 
monoclonal antibody against cytokeratin (subtype CK3), which was described as a 
specific cell marker of corneal epithelial cells (Chaloin-Dufau et al., 1990; Cubitt et al., 
1993). Corneal fibroblasts were isolated from 17-day-old chicken embryonic cornea 
and allowed to proliferate on µ-slides for 2 days without cross-link inhibitors. 
Thereafter, cells were stained by immunofluorescence with an antibody against 
cytokeratin. Nuclear DNA was visualized by DAPI staining. 
 
In the cell slides, two types of areas with abundant cells can be found. Nevertheless, 
several cytokeratin-staining cells (red) can be found in area 1 but not 2 (Figure 5-5). 
However, area 2 corresponds to the majority of areas sampled from the slides, 
whereas area 1 appeared rarely. This experiment showed the coexistence of 
keratocytes and epithelial cells in corneal fibroblast at early stage of fibril organization, 
but the amount of keratocytes was much larger than that of epithelial cells. 
 
      
 
Figure 5-5. Immunofluorescence staining of cytokeratin in corneal fibroblast ECM at day 2 in 
µ-slides (ibidi). Ethanol-fixed cultures of corneal fibroblasts, permeabilized with Triton X-100, 
were immunostained with antibody against cytokeratin (red) and were stained with DAPI 
(blue) for localization of nuclear DNA. 
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5.5.2 Even less epithelial cells exist after 14-days in cultures of corneal 
fibroblasts.  
In order to demonstrate the cell distribution at later stages of fibril organization, 
matrices from 14-days corneal fibroblasts were embedded in paraffin and 
immunofluorescence stained with antibodies against cytokeratin and collagen I. 
 
Large amounts of collagen I (green) were seen in the newly formed ECM whereas 
only very few cells labeled for cytokeratin (red) were found (Figure 5-6). These data 
indicate that the proliferation and / or the survival of epithelial cells was suppressed 
under culture conditions employed. Epithelial cells were in our cultures and are 
unlikely to have a meaningful influence on the formation of lamellae and regulation of 
diameters of collagen fibrils. 
 
   
 
Figure 5-6. Immunofluorescence staining of cytokeratin and collagen I on paraffin section of 
embedded corneal fibroblast ECM after 14-days cultivation. Paraformaldehyde-fixed cultures 
of corneal fibroblasts were embedded in paraffin and cut into thin sections. After 
deparaffinization and rehydration the sections were immunostained with antibodies against 
cytokeratin (red) and collagen I (green), and co-stained with DAPI (blue) for localization of 
nuclear DNA. 
 
5.6 Matrix components of keratocyte cultures possibly involved in cross-link 
formation  
5.6.1 Fibronectin 
Fibronectin has been well characterized as an extracellular matrix glycoprotein that 
regulates many cellular functions. It has been reported that cellular fibronectin binds 
with high affinity to lysyl oxidase and is critical for proteolytic activation of LOX 
(Fogelgren et. al, 2005). Moreover, fibronectin binds to tissue transglutaminase and 
plays a role in the assembly of ECM (Gaudry et al., 1999). Therefore, the localization 
of fibronectin was checked in keratocyte cultures under different conditions of cross-
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link formation. Keratocytes were cultured in µ-slides (ibidi) as described in 4.2.2 and 
were allowed to proliferate for 2 or 7 days. Cell layers were doubly labeled by 
immunofluorescence for fibronectin (red) and type I collagen (green). Nuclei were 
visualized by DAPI staining (blue). 
 
Immunofluorescence micrographs (Fig. 5-7) show that the deposition of fibronectin in 
the ECM already occurred at the beginning of cell proliferation (A, red). At day 7 
fibronectin was densely distributed over the whole ECM (B, red). There is no obvious 
difference in the distribution of fibronectin at day 2 and day 7 (A, B, red). The 
production and deposition of collagen I also seems to be the same and was not 
detectably influenced by cross-link inhibitors (A.B, green). Fibronectin co-distributed 
with collagen I at early phases of matrix formation already (A, merge, yellow). These 
results suggest that the deposition of fibronectin in the ECM is not affected by either 
LOX- or TG-derived cross-link formation.  
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Figure 5-7. Immunofluorescence staining of keratocytes in µ-slides (ibidi). Cells were 
cultured under 4 conditions (control, -/-; in the presence of TG-inhibitor, +/-; in the presence 
of ßAPN, -/+; and with both inhibitors, +/+) for 2 (A) or 7 days (B). Ethanol-fixed cultures, 
permeabilized with Triton X-100, were immunostained with antibodies against fibronectin 
(red), collagen I (green) and with DAPI (blue, nuclei). 
 
5.6.2 Decorin  
Decorin is a proteoglycan widely distributed in the ECM and thought to be 
responsible for the structure, tissue organization, and surface properties of fibrils. 
Decorin has a primary role in regulating fibril assembly and show a coordinated 
regulation of collagen fibrillogenesis in the cornea together with biglycan. In decorin-
null stroma, occasional abnormal fibrils were observed (Zhang et. al, 2009). 
Therefore, we were interested whether the cross-link inhibitors influence the 
deposition of decorin in the ECM. Keratocytes were cultured in µ-slides as described 
in 4.2.2 and allowed to proliferate for 2 or 7 days under different conditions of cross-
link formation. Cell layers were doubly labeled by immunofluorescence for decorin 
(red) and type I collagen (green). Nuclei were visualized by DAPI staining (blue). 
 
Decorin was deposited into extracellular space under control condition at day 2 (Fig. 
5-8 A, -/-, red, extracellular staining indicated by white arrows) whereas it remained 
mostly intracellular in the presence of cross-link inhibitors (A, +/-, -/+ and +/+, red). 
After 7-day of cultivation, decorin was deposited into all of the extracellular space. 
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Moreover, micrographs suggest that ßAPN reduced the intensity of the decorin signal 
at day 7 (B, -/- -/+ versus -/+ +/+). But such differences of signal intensity may be 
caused by the mode of matrix deposition which can be demonstrated only at higher 
magnifications. The data suggest co-localization of collagen I and decorin at day 7 (B, 
merge, yellow).  
 
 
 
 
Figure 5-8. Immunofluorescence staining of keratocyte in µ-slides (ibidi). Cells were cultured 
under 4 conditions (control, -/-; in the presence of TG-inhibitor, +/-; in the presence of LOX-
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inhibitor ßAPN, -/+; and with both inhibitors, +/+) for (A) or 7 days (B). Ethanol-fixed cultures, 
permeabilized with Triton X-100, were immonostained with antibodies against decorin (red), 
collagen I (green) and with DAPI (blue, nuclei). 
 
5.6.3 Collagen type VI 
Type VI collagen is a ubiquitous matrix protein. It is a major component in human 
corneal stroma and exists also in chicken cornea. The collagen VI microfibril is highly 
disulfide cross-linked and contributes to a network of beaded fiaments interwoven 
with other collagen fibrils (von der Mark et. al, 1984). Because of the ubiquitous 
distribution of collagen VI and its relationship with cross-links, the localization of 
collagen VI was investigated in keratocytes cultures. Cells were cultured in µ-slides 
as described in 4.2.2 and were allowed to proliferate for 2 or 7 days under different 
conditions of cross-link formation. Cell layers were doubly labeled by 
immunofluorescence for collagen VI (red) and type I collagen (green). Nuclei were 
visualized by DAPI staining (blue). 
 
Immunofluorescence micrographs (Fig. 5-9) show that the deposition of collagen VI 
in ECM occurred at the beginning of cell proliferation and fibril organization (A, red). 
There is no apparent difference of the distribution of collagen VI at day 2 and day 7 
(A,B, red), and also was not affected by LOX-and TG-derived cross-link formation. 
These data suggest that collagen VI was co-distributed with collagen I at early phase 
of matrix formation already (A, merge, yellow).  
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Figure 5-9. Immunofluorescence staining of keratocytes in µ-slides. Cells were cultured 
under 4 conditions (control, -/-; in the presence of TG-inhibitor, +/-; in the presence of LOX-
inhibitor ßAPN, -/+; and with both inhibitors, +/+) for 2 (A) or 7 days (B). Ethanol-fixed 
cultures, permeabilized with Triton X-100, were immunostained with antibodies against 
collagen VI (red), collagen I (green) and with DAPI (blue, nuclei). 
 
5.7 Effect of crosslink inhibitors  
5.7.1 Tissue transglutaminase was effectively inhibited by TG-inhibitor in 
keratocytes 
The activity of transglutaminase in cell culture was measured by addition of 
fluorescence-labeled cadaverine, a primary amine donor for detecting the 
endogenous substrates for active TG (Lajemi et al., 1997). Keratocytes were cultured 
in the presence of Alexa Fluor® 555 (Invitrogen)-conjugated cadaverine and 
visualized by immunofluorescence microscopy, as described in 4.10.  
 
Under control conditions, strong signals of Alexa Fluor® 555 (red) documented the 
existence of TG activity in keratocyte cultures (A), while the matrix showed much 
weaker signals in the presence of 5 µM TG-inhibitor (B). These results validated the 
effective inhibition of TG activity in keratocytes by the addition of the TG-inhibitor. 
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Figure 5-10. The activity of tissue-transglutaminase was proved in the cell cultures by 
addition of fluorescent-labelled cadaverine as a potential substrate.  
 
5.7.2 Lysyl oxidase activity is detectable and varied during the process of 
keratocytes proliferation.  
The activity of LOX in keratocytes was monitored during the cell growth by a tritium-
release assay (see 4.9). The enzyme activity was tracked for 6 days. After 24h 
cultivation, LOX-activity was already detectable and was discontinuous over a 6-day 
culture period. At day 3 it reached a maximum, decreased subsequently to a 
minimum at day 4 and thereafter, increased at least until day 6 (Fig. 5-11). The 
changes of LOX-activity in keratocytes suggested that LOX had distinct effects on 
collagen fibril organization as time progressed in corneal fibroblast proliferation. 
 
                      
 
Figure 5-11. The activity of lysyl-oxidase in corneal fibroblast was measured per a tritium-
release assay using L-[4, 5-3H]lysine labeled chick aortas as elastin substrate. 
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5.8 Determination of absolute collagen amounts produced by keratocytes in 
culture 
Total collagen was assessed in order to determine the absolute collagen amounts 
deposited in matrices of keratocytes. This assay is based on the detection of 
hydroxyproline (see 4.8).   
 
The proteins were extracted from the 3D matrices deposited after 2-days or 14-days 
of culture under different conditions of cross-linking. At day 2, matrices under control 
conditions (-/-) represented highest collagen deposition whereas matrices in the 
presence of both cross-link inhibitors (+/+) had the lowest collagen amount. Matrices 
with TG- or LOX-inhibitor (+/-, -/+) contained intermediate amount of collagens in 
comparison to controls (Fig. 5-12, A). Similarly to the cultures at day 2, matrices at 
day 14 showed also a highest collagen level in controls (-/-) and lowest level when 
both inhibitors were applied (+/+). In comparison with ßAPN (-/+), the addition of TG-
inhibitor led to small collagen quantities deposited into the matrices (+/-) (Fig. 5-12, 
B). Inhibition of LOX- or/and TG-derived cross-link formation does not lead to a 
drastic reduction of collagen deposition in matrices at day 2 and day 14. Additionally, 
purified tendon collagen I isolated from 17-day-old chicken embryos and bovine 
albumin (SERVA) were measured in parallel as positive and negative controls 
proving the specificity of this “total collagen assay” (Fig. 5-12, C). 
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Figure 5-12. Total collagen assay, which based on hydroxyproline measurement, was 
performed of keratocytes at day 2 (A), day 14 (B). Tendon collagen I and bovine albumin 
were parallel measured as positive and negative controls (C). 
 
5.9 In-vitro experiments indicated that TG controls fibril diameter, whereas 
factor XIII does not. 
5.9.1 Turbidity curves of in-vitro fibrillogenesis with crude corneal collagen 
mixture in the presence of TG or factor XIII 
Factor XIII is a transglutaminase abundantly occurring in keratocyte cultures 
(component of FCS). The enzyme catalyzes cross-linking of proteins with the same 
isopeptide bond as tissue transglutaminases. Therefore, we investigated the effects 
of factor XIII on corneal collagen fibril organization. Crude collagen mixtures without 
proteoglycans were isolated from 17-days embryonic cornea. Fibrillogenesis was 
initiated by adjusting the solutions to appropriate conditions and was monitored by 
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turbidity measurements (4.3.1). Human recombinant human tissue transglutaminase 
(rhTG) and coagulation factor XIII from human plasma were added to the 
reconstitution mixtures direct after dilution with water. Both enzymes are 
commercially available from ZEDIRA and are Ca2+-dependent. In addition, factor XIII 
must be activated by thrombin.  
 
In the presence of activated rhTG (Fig. 5-13, A, red) the curve achieved higher 
plateau levels of turbidity than the controls (A, blue). It is noteworthy that a sudden 
increase of turbidity appeared at the onset of fibrillogenesis (A, red, black arrow). 
This phenomenon was not detectable in controls. The results may imply that small 
aggregates of collagens were formed at the initial phase of fibrillogenesis, which may 
be very important to subsequent fibril organization. On the other hand, in the 
presence of activated factor XIII (Fig. 5-13, B, red) we observed lower plateau levels 
of turbidity than in controls (B, blue). There are no obvious effects detectable at the 
onset phase of fibril formation. Additionally, a delayed lag phase in turbidity occurred 
with activated factor XIII (B, red) in comparison with the controls (B, blue). 
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Figure 5-13. In-vitro fibrillogenesis of mixtures of crude cornea collagen in the presence of 
rhTG (A) or factor XIII (B), monitored by development of turbidity at 313 nm. In both cases 
blue curve indicates control condition while red curve indicates the activated condition. rhTG 
or factor XIII were added at the beginning of fibrillogenesis. 
 
5.9.2 Diameter distribution of fibrils reconstituted in the presence of activated 
TG or factor XIII 
In-vitro fibrillogenesis was performed with different amounts of enzymes. Again, the 
crude corneal collagen mixtures without proteoglycans were used (see 4.3.1). 
Reconstituted products were directly adsorbed to nickel grids, negatively stained with 
uranyl acetate, and observed with a transmission electron microscope. Fibril 
diameters were analyzed in all cases (Fig. 5-14). Fibrils reconstituted under control 
conditions (collagen mixtures with CaCl2) represented a diameter distribution of 
545.60 ± 142.29 nm, n = 215 (A). In the presence of activated rhTG, the fibrils 
became thinner in a dose-dependent manner. Addition of 2 µg rhTG led to a diameter 
distribution of 398.20 ± 104.11 nm, n = 226 (B), and 4 µg rhTG led to a distribution of 
302.60 ± 101.72 nm, n = 115 (C). In the presence of activated factor XIII the diameter 
of reconstituted fibrils did not change in comparison with controls. They had a 
distribution of 553.74 ± 146.82 nm, n = 42 (25 µg factor XIII) or 610.51 ± 168.68 nm, 
n = 71 (50 ug factor XIII). 
 
These results illustrate that tissue transglutaminase controls fibril diameters in “in-
vitro systems”, even when collagen preparations already containing cross-links were 
used as starting material. Factor XIII has no effect on diameter control of corneal 
collagen fibrils.  
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Figure 5-14. Analysis of fibril diameter distribution: The diameter of collagen fibrils were 
measured of reconstituted products from 3h-fibrillogenesis of crude mixture alone (A), in the 
presence of a recombinant human tissue transglutaminase (His6-rhTG2) (B, C) or a 
coagulation factor XIII from human plasma (D, E) by electron microscopy. 
 
5.9.3 Morphologic changes of fibrils 
Although we have shown that the reconstituted fibrils became thinner in the presence 
of activated rhTG, the “thin fibrils” had a mean diameter around 300 nm. Not only the 
thickness, but also the morphology of fibrils was different from fibrils in authentic 
corneal stroma. Therefore, a corneal collagen mixture still containing proteoglycans 
was used as starting materials in further fibrillogenesis experiments (see 4.3.2). In-
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vitro experiments were done as described in 5.9.1 and the reconstituted products 
were investigated by transmission electron microscopy. 
 
Interestingly, network-like structures can be found only in the reconstituted products 
with activated rhTG (Fig. 5-15 B). High magnification showed that those network 
structures were labeled with antibodies to collagen I (gold particles highlighted with 
red arrows, Fig. 5-15 B inset). Such collagen fibril containing networks were not 
apparent under control condition (A). These results may imply that proteoglycan 
components (such as decorin, lumican, biglycan etc.), as well as activity of tissue 
transglutaminase contributes to formation of thin fibrils with diameters of about 45 nm, 
approaching the diameter of authentic corneal fibrils. 
 
 
 
Figure 5-15. Fibrils reconstituted in-vitro from crude corneal collagen mixture with 
proteoglycan: electron micrograph of fibrils from in-vitro fibrillogenesis in the presence of not 
activated rhTG (A) or of activated rhTG (B). Collagen type I is heavily labeled with antibody 
gold conjugates indicated by red arrows in the inset of B. Bars: 200 nm. 
 
5.10 The cross-link dependent collagen fibril formation in chicken embryonic 
tendon 
The fibrillar organization in cornea and tendon are vastly different although both 
tissues contain collagens I and V as their major collagenous components. Mature 
cornea consists of orthogonally stacked lamellae formed by uniformly thin collagen 
fibrils evenly spaced in parallel whereas mature tendons contain fibrils with 
heterogeneous diameters arranged into parallel fibrous bundles. From this point of 
view, I was interested at the beginning of my study in the suprastructures of matrices 
RESULTS 
	   69	  
deposited by keratocytes or tenocytes from cornea or metatarsal tendons with and 
without cross-link formation. During the development of studies, cornea exhibited 
more important aspects to a cross-link-dependent fibril organization. Therefore, I 
focused my study mostly on cornea. However, some principles of “cross-link 
dependent collagen fibril formation in chicken embryonic tendon” were investigated in 
the studies described below. 
 
5.10.1 Suprastructures of matrices deposited by tenocytes 
Collagenous matrices with and without ßAPN were obtained from 3D-cultures of 
tenocytes isolated from metatarsal tendons of 17-day-old chick embryos and 
cultivated for 14 days. The arrangement of the collagen fibrils and the fibril diameter 
distribution with and without cross-link formation were analyzed on ultrathin sections 
of 3D matrices by electron microscopy. 
 
In cultures of tenocytes, a small number of discrete bundles (Fig. 5-16 A) contained 
fibrils arranged in parallel arrays in the absence of ßAPN. Such structures of bundles 
were very similar to those of metatarsal tendons. Otherwise, irregular fibril 
arrangements and disorganized matrices were formed in the presence of ßAPN (D). 
This implies that LOX controls collagen organization also in embryonic tendon. 
 
 
 
Figure 5-16 Suprastructures of matrices deposited by tenocytes. Control condition allowing 
for LOX-derived cross-link formation (A-C) or in the presence of LOX-inhibitor ßAPN (D). 
Small gold particles in micrograph D indicate the localization of collagen I. Bars: 200 nm. 
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5.10.2 Addition of ßAPN changed the fibril diameter distribution in tenocytes. 
Analysis of fibril diameter distribution contributes further morphological details of the 
collagen fibrils formed by tenocytes in culture. The diameter of collagen fibrils was 
measured on images from ultrathin sections of 17-day-old embryonic chicken tendon 
(Fig. 5-17 A) or from cultures of tenocytes from 14-day-old chicken embryos (B, C). 
Fibrils formed by tenocytes under control conditions showed a similar diameter 
distribution (B: 54.60 ± 8.62 nm, n = 604) comparing with the fibrils in metatarsal 
tendon tissue (A: 56.35 ± 11.33 nm, n = 701). In the presence of ßAPN the fibrils 
became thinner and had a broader distribution (C: 45.78 ± 14.12 nm, n = 517).  
The results suggest that the arrangement of parallel fibrils and fibril bundles have a 
relationship to LOX-derived cross-links. Cross-links of collagens also contribute to 
fibril diameter control in tendon, for maintaining the thickness and arrangement of 
tendon fibrils. 
 
                              
Figure 5-17. Analysis of fibril diameter distribution: The diameter of collagen fibrils were 
measured on ultrathin sections of authentic tissue (A) or of 3D matrices from chick cultures of 
tenocytes from metatarsal tendons by electron microscopy (B, C). 
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5.10.3 Lysyl oxidase activity is detectable and varied during the process of 
tenocytes proliferation.  
The activity of lysyl oxidase in tendon fibroblast was also measured during the cell 
growth by a tritium-release assay (see 4.9). The measurement of activity was tracked 
for 6 days. After 24h cultivation, LOX-activity was detectable and was discontinuous 
over a 6-day period. Similarly to keratocytes, it reached a maximum at day 3. 
Thereafter, LOX activity decreased until cultures were discontinued at day 6  (Fig. 5-
18). The changes of LOX-activity in tenocytes suggested that LOX had distinct 
effects on collagen fibril organization as time progressed in tendon fibroblast 
proliferation. These effects are also different from those in corneal cultures. 
 
                     
 
Figure 5-18. The activity of lysyl-oxidase in tendon fibroblast was measured per a tritium-
release assay using L-[4, 5-3H]lysine labeled chicken aortas as elastin substrate. 
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6. DISCUSSION 
       
The size and organization of collagen fibrils within the ECM are crucial parameters 
for tissue structure and function. Corneal fibrils are heterotypic fibrils containing 
collagen I co-assembled with collagen V. Tendon fibrils contain predominantly of 
collagen type I, and to a lesser degree collagens III and V. Although both tissues 
contain similar collagenous components, the fibrillar organizations are vastly different. 
Mature cornea consists of orthogonally stacked lamellae formed by uniformly thin 
collagen fibrils evenly spaced in parallel. In contrast, tendons contain fibrils with 
heterogeneous diameters arranged into parallel fibrous bundles. 
 
The aim at the beginning of my work was to obtain further insight into the molecular 
control of fibril formation in in-vitro experiments by finding differentially expressed 
matrix proteins in tendon and corneal fibroblast cultures. The proteins produced in 
these cultures were to be analyzed by 2D-electrophoresis, followed by identification 
of differential protein spots by mass spectrometry. But I got no exciting results using 
these biochemical methods. Thereafter, a change of the culture conditions led to a 
delectable finding. In our lab the routine fibroblast cells are cultured with supplement 
of ßAPN, in order to reduce the collagen cross-linking. In my 3D cell cultures I was 
not satisfied with the dense of matrix deposition using the routine method. A remove 
of ßAPN may increase the matrix deposition in fibroblast cell cultures. Also, a 
fortuitous discovery came out when this new culture condition was employed.  
 
The essential role of covalent collagen cross-links in tissue-specific fibril formation 
became evident with the seminal observations that fibrils in primary cultures of 
chicken embryonic keratocytes had a typical lamellar organization that was disrupted 
in the presence of ßAPN. Furthermore, the introduction of γ-glutaminyl-ε-lysyl 
isopeptide bonds by tissue transglutaminase was required for the tight restriction of 
fibril diameters. This was lost in the presence of transglutaminase inhibitors. 
Therefore, in addition to lysyl oxidase, another important enzyme introducing 
collagen cross-links, i.e. tissue transglutaminase, has been identified in my work as 
an essential instrument of corneal matrix organization. 
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 The same culture conditions were applied in tendon fibroblasts. Although parallel 
organization of fibrils and few discrete bundles of fibrils were found in the absence of 
ßAPN, the importance of cross-links was less prominent. 
 
In this study, the original materials, collagens and cells, were from 17-day-old chicken 
embryos. Thus, all discussions and conclusions apply to this avian species and it 
remains to be investigated whether or not they can be extended to other organisms. 
The issue of corneal matrix organisation has been addressed predominantly by three 
complementary approaches: 
(i) suprastructural analysis of electron micrographs derived from ultrathin sections of 
authentic tissues and matrices deposited in cell cultures; 
(ii) immunofluorescence analysis of ECM components of interest on cell cultures; 
(iii) in-vitro fibrillogenesis of purified collagens or mixtures thereof and analysis of the 
reconstituted fibrils by electron microscopy. 
 
These strategies were implemented for cornea and metatarsal tendon tissues, for 
matrices deposited in 3D keratocytes and tenocytes, and for keratocytes proliferated 
directly on µ-slides. Small tissue pieces or cell matrices were embedded and cut into 
ultrathin sections for examination by electron microscopy or immuno-gold electron 
microscopy. After negative staining the fibril suprastructures were visualised in more 
details. In addition, compositional analysis is possible at early time points directly on 
the ECM deposited by the cells on µ-slides. In the 30 µl volume, keratocytes grow to 
confluence within two days. Moreover, collagen mixtures extracted and purified from 
authentic embryonic cornea were employed for in-vitro reconstitution. The in-vitro 
data complemented the results from cell culture system.  
 
6.1 Cross-link dependent tissue-specific fibril formation and matrix 
organization in chicken embryonic cornea and tendon 
The corneal stroma is unique in having a homogeneous distribution of small diameter 
fibrils that are regularly packed within lamellae and this arrangement minimises light 
scattering and permits transparency. The formation of small-diameter fibrils is 
commonly thought to be controlled by the globular domains of type V collagens (Birk 
et al., 1990; Marchant et al., 1996; Birk, 2001), or by co-assembly of the collagenous 
cores of the fibrils with decorin, biglycan (Zhang et al., 2009; Rada et al., 1993) or 
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lumican (Chakravarti et al., 1998, 2000; Rada et al., 1993).  However, the formation 
of these thin fibrils into orthogonal stacked lamellae has not been explained. Ruberti 
and co-workers have shown that human corneal fibroblasts in culture produced 
lamellae of fibrils with similarity to the developing mammalian cornea (Guo et al., 
2007). In this study, primary cultures of corneal fibroblasts were generated after their 
emigration from pieces of stromal tissue and the cells were passaged after 2-weeks 
of cultivation. Nevertheless, some questions have not been answered, e.g. how the 
lamellae of fibrils build in fibroblast cell cultures; it is still unknown that which factors 
or mechanism involve in this process. In the present work, fibroblast cells were 
isolated from chicken corneas digested with bacterial collagenase. In this way, matrix 
deposition and cross-linking occurred de novo after cell proliferation. Therefore, a 
study of the influence of cross-link formation on matrix organization in cell cultures 
could be achieved. A correlation between cross-link formation and suprastructural 
organization in cornea, especially with respect to diameter control of fibrils and their 
organization into lamellae has not been established before. 
 
A major observation of the present work was that the unique suprastructure of 
corneal fibrils indeed depended on cross-linking. Cross-link inhibitors were added at 
the beginning of collagen production in cell cultures and, therefore, could exert their 
influence already at very early stages of fibril formation. The total collagen amounts 
deposited in matrices of keratocytes were measured and it was shown that cross-link 
inhibitors did not appreciably reduce collagen production. The arrangement of 
collagen fibrils in 3D keratocyte cultures was very similar to that in the developing 
chicken corneal stroma. Typical stacks of orthogonal sheets of parallel collagen fibrils 
were formed by keratocyte cell cultures in the absence of the cross-link inhibitor 
ßAPN. Such lamellae were not apparent in cultures with ßAPN. Therefore, LOX-
derived cross-link formation is essential for fibril arrangement into lamellae in chicken 
cornea. By contrast, the diameter control in individual fibrils not only depended on 
collagen V (Birk et al., 1990, 2001) and SLRPs (Zhang et al., 2009; Chakravarti et al., 
1998, 2000; Rada et al., 1993) but also on cross-linking. However, the chemical 
nature of such cross-links was isopeptide bonds introduced by tissue 
transglutaminases, but not factor XIII. Thicker fibrils with clearly visible banding 
pattern were formed in the presence of TG-inhibitor whereas the orthogonal 
arrangement of fibrils remained intact. Thus, TG-derived isopeptide cross-linking 
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seems to be an additional important requirement for a stringent control of fibril 
diameters to generate homogeneously thin fibrils in chicken cornea. A loss of both 
lamellae organization and diameter control of fibrils appeared when the formation of 
both LOX- and TG-derived cross-links was prevented. Interestingly, many thin fibrils 
with diameters of 20-25 nm which are even thinner than the authentic corneal fibrils 
were observed. However, structurally disrupted and thick fibrils were also observed in 
addition to the typically thin corneal fibrils. These results imply some functional 
connections between the formations of both cross-links. The suprastructural 
regulation in corneal fibrils is a mechanism with complementarity of LOX- and TG-
derived cross-links. We presume that the stabilization of aggregates formed early 
during fibrillogenesis is essential for a tissue-specific outcome, i.e. the typical matrix 
organization in chicken embryonic cornea.  
 
Analogous experiments were performed with tenocytes which resulted in comparable 
phenomena. Tendon tissue-specific bundles of fibrils and fibrils arranged in parallel 
were found only in controls allowing LOX-derived cross-link formation, albeit in low 
numbers. Such bundles were not apparent in cultures with ßAPN. The distribution of 
fibril diameters also changed slightly in the presence of ßAPN towards thinner fibrils 
with a broader diameter distribution. Thus, we conclude that LOX-activity may control 
collagen organization into bundles and parallel fibrils also in embryonic tendon at the 
tissue-level. LOX may also contribute to fibril diameter control and the maintenance 
of the thickness and tensile strength of chicken tendon fibrils. 
 
Furthermore, amino acid analysis of cell layers deposited in 14-days corneal and 
tendon fibroblasts was carried out (in cooperation with Prof. Jürgen Brinckmann, 
Institute of Virology and Cell Biology, University of Lübeck). The raw data showed 
different contents of each amino acid in both cell cultures, especially with respect to 
hydroxyproline, proline, glycine and tyrosine. These data may contribute towards an 
explanation of different extents and the nature of cross-link formation in keratocytes 
and tenocytes. However, these data cannot be interpreted strictly because the 
matrices could not easily be separated from the cells. Hence, the values obtained 
correspond to crude mixtures of proteins derived from both the matrices and the cells. 
Distinct cell numbers in the respective cultures also could influence the measurement. 
Trypsin digestion of cell layers to separate the matrices from cells may be a partial 
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solution to this problem which, however, will leave intact collagenous but not non-
collagenous matrix components. 
  
 
Cornea Tendon 
Hyp 126,30 98,66 
Asp 41,41 48,38 
Thr 21,20 20,78 
Ser 27,60 27,11 
Glu 64,97 72,57 
Pro 141,46 124,25 
Gly 289,84 325,80 
Ala 84,22 99,62 
Val 21,77 17,33 
Met 8,43 7,68 
Ile 14,90 13,17 
Leu 31,66 26,74 
Tyr 8,00 4,80 
Phe 16,21 14,35 
His 11,42 7,18 
Hyl 18,91 16,93 
Lys 25,00 21,74 
Arg 46,71 52,91 
Hyp/Pro 0,893 0,794 
Hyp/(Hyp+Pro) 0,472 0,443 
Hyl/Lys 0,757 0,779 
Hyl/(Hyl+Lys) 0,431 0,438 
Hyl/Hyp 0,150 0,172 
µg Protein inj. 1,50 5,68 
µg  Protein/sample 300,96 1136,63 
µg Collagen 373,60 1130,12 
 
Figure 6-1.  Amino acid analysis of matrices deposited in 14-days corneal or tendon 
fibroblasts (residues per 1000, without cysteine) (In cooperation with Brinckmann, Uni. 
Lübeck). 
 
6.2 Analysis of LOX- and TG-derived cross-links in chicken keratocytes 
Different tissue types showed distinct patterns of cross-linking chemistry, though 
most of them were essentially based on the reactions of peptide-bound aldehydes 
created from specific lysine, hydroxylysine side chains during the assembly of 
collagen subunits into fibrils. Reports are found in the literature on the basic 
mechanisms, the principal pathways, and the interaction sites of collagen cross-
linking analyzed directly by several techniques. These techniques included labeling 
of reducible cross-links with tritiated borohydride, isolating them for structural analysis 
after proteolysis or acid hydrolysis as tritiated peptides or amino acids, and similarly 
by monitoring 3-hydroxypyridinium cross-linking residues by their inherent 
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fluorescence (Eyre et al., 1984, 1987, 2005). New methods were also developed in 
recent years, such as peptide isolation by HPLC followed by sequence analysis or 
protein mass spectrometry (Eyre et al., 2008). The TG-derived cross-links base on 
the reaction of γ-glutaminyl-ε-lysyl isopeptide bonds. The isopeptide can be 
hydrolyzed by both acid and alkali hence isolation and identification involves 
extensive enzyme digestion. Its presence can be detected by antibodies to the cross-
link and indirectly by amino acid analyses before and after fluorodinitrobenzaldehyde 
(FDNB) derivativization to distinguish free and bound ε-amino lysine residues (Fratzl 
ed., 2008).  
 
In the present work, collagen-fluorography using 14C-proline labeled keratocytes was 
carried out to indirectly visualize all the chains of collagens and collagen cross-linking 
products in cell culture. Detailed analysis of the chains visualized by collagen-
fluorography showed that separate LOX-dependent as well as LOX- and TG-
dependent cross-link products co-existed in keratocytes. However, formations of both 
cross-links in the ECM are not synchronous. Thus, their influences on fibril assembly 
are time-dependent. For further details of the structure of cross-links, e.g. of cross-
links between staggered or unstaggered collagen molecules within the fibrils, mass 
spectrometry of cross-linked peptides will be necessary. Cross-link products 
containing lysyl- or glutamine-modified peptides can also analyzed in this manner.  
 
6.3 Matrix components of keratocyte cultures possibly involved in cross-link 
formation 
Collagen V, which constitutes 15-20% of the fibrillar collagens in cornea, is 
considered as an important factor specifying the thin fibrils with uniform diameter in 
cornea tissue (Birk et al., 1990; Marchant et al., 1996). Collagen VI is present as a 
network throughout chicken secondary stroma (Doane et al., 1992). Decorin and 
fibronectin are both ubiquitous components of ECM that were shown to interact with 
collagen molecules. Decorin has been shown to associate with collagen fibrils in 
many connective tissues including corneal stroma (Fleischmajer et al., 1991). It 
associates with collagen I and leads to a delayed initial assembly of collagen 
molecules resulting a decreased fibril diameter (Vogel and Trotter, 1987). In addition, 
fibronectin can bind to tissue transglutaminase (Radek et al., 1993) and also acts as 
a scaffold for active LOX (Fogelgren et al., 2005). Furthermore, fibronectin binds and 
DISCUSSION 
	   78	  
enhances the activity of BMP-1, which is required for LOX activation. Based on these 
arguments the corresponding corneal components were investigated in keratocyte 
cultures. 
 
α-Chains of collagens were metabolically labeled with 14C-proline in keratocyte 
cultures, digested with pepsin, and analysed by PAGE and fluorography. In the 
present work, different behaviors were demonstrated of collagen V at early and later 
time points of fibrillogenesis in corneal matrices which was also influenced by cross-
link inhibitors. The results imply that the cross-link formation affects the proportion of 
collagen V in formed corneal fibrils in a time-dependent manner. In keratocytes, 
deposition of collagens changed during cell proliferation: the proportion of α2(I)- and 
α1(I)-chains changed slightly; LOX inhibitor decreased while TG-inhibitor increased 
the relative amount of collagen V; and simultaneous application of both inhibitors led 
to a slightly reduction of collagen V at day 6. Since collagen V is considered as an 
essential regulator in heterotypic collagen I/V fibrils, this change of collagen I/V 
proportions could change the pathway of fibrillogenesis and fibril organization 
because the corneal fibrils are heterotypic I/V fibrils. 
 
In the present work, immunofluorescence staining of fibronectin and collagen VI in 
the ECM were nearly the same under four different conditions of cross-link formation. 
These results suggested that the synthesis and deposition of neither fibronectin nor 
collagen VI were altered by suppression of LOX- or TG-derived cross-link formation. 
On the other hand, the results showed that the deposition of decorin into ECM was 
delayed by either LOX- or TG-inhibitors. Thus, deposition of decorin was affected by 
both LOX- and TG-derived cross-link formations during the initial phase of cell 
proliferation and fibril formation. The correlative functions of LOX-derived cross-link 
formation and deposition of decorin into ECM may explain LOX-dependent 
differences in suprastructural organization of corneal fibrils, especially concerning the 
formation of lamellae. 
 
6.4 In-vitro reconstitution of crude corneal collagens   
The assembly of collagen molecules into fibrils is an entropy-driven process, similar 
to that occurring in other protein self assembly systems, such as microtubules, actin 
filaments and flagella (Kadler et al., 1987). The fibril-forming collagens in embryonic 
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chicken are synthesized as soluble procollagens, and then are converted into 
collagens by specific enzymatic cleavage of terminal propeptides by the procollagen 
metalloproteinases. Without these proteinases the synthesis of collagen fibrils would 
not occur. Collagens extracted in acetic acid from authentic tissue are triple helical 
monomers without N- and C-propeptides. Therefore, they are capable to reconstitute 
into fibrils under suitable conditions, e.g. appropriate buffer salts, pH, and 
temperature. In-vitro reconstitution of collagens into fibrils is a well-established 
strategy for a time-dependent observation of collagen fibril formation (Birk and Silver, 
1984; McPherson et al., 1985; Birk et al., 1990; Hansen and Bruckner, 2003; Trelstad 
et al., 2006), sometimes modulated by the presence non-collagenous matrix 
components.  
 
In the present work, the structure and organization observed for fibrils reconstituted 
in-vitro in the presence of rhTG complemented and corroborated the results from the 
cell culture experiments in the presence of TG-inhibitor. In the presence of rhTG or 
factor XIII crude corneal collagens were differentially reconstituted into fibrils in-vitro. 
A sudden increase in turbidity at the initiation time of fibrillogenesis is consistent with 
the formation of specific early aggregates supported by TG activity at the beginning 
of fibril organization. Such small aggregates may serve as a nucleation site 
accelerating the formation of a large number of thin, tissue-specific corneal fibrils. 
Furthermore, analysis of diameter distribution showed that rhTG activity favored the 
formation of thin fibrils with crude corneal collagen mixtures. However, another 
transglutaminase, the factor XIII, does not have this capability. Interestingly, we also 
found that network-like structures composed of thin, banded, collagen I-containing 
fibrils only appeared in the reconstituted products in the presence of proteoglycans 
and TG activity. Here, fibrils reconstituted in-vitro from crude corneal collagens 
without proteoglycans exhibit obviously larger diameters in comparison to authentic 
corneal fibrils. In the presence of proteoglycans, fibrils became much thinner and 
similar to authentic 20-35 nm-fibrils. Therefore, we were able to show that two factors 
are essential for fibril diameter control in corneal stoma: co-polymerization of 
proteoglycans as well as the enzymatic activity of tissue transglutaminase (and not 
factor XIII).  
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In this experiment, the original materials of crude collagens should contain some 
cross-links, since initial cross-links were formed already in 17-day-old embryonic 
chicken cornea. We have tried to purify collagens from cell cultures of keratocytes in 
the presence of both LOX- and TG-inhibitors, in order to harvest more cross-link free 
material for reconstitution experiments. Because of the low yield of collagens in cell 
culture, as well as the loss during purification process, I failed to get enough 
materials for further experiments.  To enlarge the cell culture system, to concentrate 
the purified collagen mixture, and to reconstitute fibrils directly on EM-grids in very 
small volumes, may represent possible strategies to achieve fibril reconstitution 
unaffected by a contribution of pre-existing cross-links.  
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7. CONCLUSIONS AND FUTURE PERSPECTIVES 
	  
The data accumulated in this thesis show that the formation of cross-links is essential 
for the tissue-specific fibrillogenesis and matrix organization in chicken embryonic 
cornea and tendon. In cornea, the organization into lamellae was strongly effected by 
lysyl oxidase-derived cross-links whereas transglutaminase-derived cross-links have 
special effects on fibril diameter control. The inhibition of both LOX- and TG-derived 
cross-links leads to a loss of matrix organization (e.g. lamellae) and broad fibril 
diameter distribution with abnormal fibril morphology. Further, the deposition of 
collagen V and decorin into extracellular matrix was affected by alterations of cross-
link formation. Parallel arrangement of fibrils and discrete bundles present in tendon 
fibroblast also depends LOX-derived cross-linking. 
 
These observations and conclusions lead to the following prospections: (i) what is the 
mechanism of LOX-derived cross-link formation leading to an organization of fibrils 
into lamellae; (ii) do the early formed cross-linked small aggregates affect the further 
fibrils organization; (iii) which other factors are required for such tissue-specific matrix 
organizations; (iv) are there some transport canals, projections of the plasma 
membrane or some other special structures which may contribute to the orientation of 
corneal collagen fibrils into orthogonal arrangements.  
 
Several methods are available helping to answer those questions, e.g. mass 
spectrometric analysis of cross-linked peptides which were deposited in fibroblast 
cultures; morphological studies of cross-linked small aggregates at early stage of 
fibrillogenesis on EM-level; employing purified LOX in in-vitro fibrillogenesis 
experiments; introduction of LOX siRNA into keratocyte cultures; analysis of 
differentially expressed matrix proteins under different cross-linking conditions using 
2D electrophoresis. In addition, other components of interest, which may also involve 
in fibril formation and matrix organization in chicken cornea, should be studied. 
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